10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: December 31, 2012

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-31990

TEL-INSTRUMENT ELECTRONICS CORP

(Exact name of registrant as specified in its charter)

New Jersey	22-1441806
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

One Branca Road

East Rutherford, NJ 07073

(Address of principal executive offices)

(201) 933-1600

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days.  Yes ý   No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.  Yes ý   No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨   No ý

As of February 18, 2013, there were 3,011,739 shares outstanding of the registrant’s common stock.

TEL-INSTRUMENT ELECTRONICS CORP

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION
		Page
Item 1.	Financial Statements.
		3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.
		16
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.
		20
Item 4.	Controls and Procedures.
		20
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings.	21
Item 1A.	Risk Factors.	21
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	21
Item 3.	Defaults Upon Senior Securities.	21
Item 4.	Mine Safety Disclosures.	21
Item 5.	Other Information.	21
Item 6.	Exhibits.	22
Signatures		23

PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements

TEL-INSTRUMENT ELECTRONICS CORP

CONDENSED CONSOLIDATED BALANCE SHEETS

	December 31, 2012			March 31, 2012
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	98,794			413,195
Accounts receivable, net		652,916			1,694,636
Unbilled government receivables		1,051,657			1,780,381
Inventories, net		6,804,031			5,023,975
Prepaid expenses and other		93,874			220,255
Deferred debt expense		148,727			108,321
Deferred income tax asset		1,099,169			1,288,631
Total current assets		9,949,168			10,529,394
Equipment and leasehold improvements, net		607,546			706,870
Deferred debt expenses – long-term		183,544			264,784
Deferred income tax asset – non-current		2,057,765			948,489
Other assets		56,872			56,872
Total assets		12,854,895			12,506,409
LIABILITIES & STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion long-term debt		1,187,534			542,382
Capital lease obligations – current portion		72,023			64,675
Accounts payable		4,373,431			3,223,291
Deferred revenues – current portion		24,426			34,767
Accrued payroll, vacation pay and payroll taxes		369,455			440,116
Accrued expenses		1,174,606			1,702,052
Total current liabilities		7,201,475			6,007,283
Subordinated notes payable-related parties		250,000			250,000
Capital lease obligations		94,607			149,582
Deferred revenues		1,853			4,637
Warrant liability		200,634			355,290
Long-term debt, net of debt discount		1,333,377			1,490,302
Total liabilities		9,081,946			8,257,094
Commitments
Stockholders' equity:
Common stock, par value $.10 per share, 3,000,639 and 2,684,215 issued and outstanding        as of December 31, 2012 and March 31, 2012, respectively		300,061			268,421
Additional paid-in capital		7,057,117			5,921,441
Accumulated deficit		(3,584,229	)		(1,940,547	)
Total stockholders' equity		3,772,949			4,249,315
Total liabilities and stockholders' equity	$	12,854,895		$	12,506,409

See accompanying notes to condensed consolidated financial statements.

3

TEL-INSTRUMENT ELECTRONICS CORP

 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended						Nine Months Ended
	December 31, 2012			December 31, 2011			December 31, 2012			December 31, 2011
										(Restated)
Net sales	$	2,350,020		$	3,673,235			5,922,258		$	11,337,800
Cost of sales		1,896,652			2,227,856			4,582,773			6,547,563
Gross margin		453,368			1,445,379			1,339,485			4,790,237
Operating expenses:
Selling, general and administrative		587,146			724,636			1,927,380			2,191,332
Engineering, research and development		481,055			633,136			1,608,459			2,160,107
Total operating expenses		1,068,201			1,357,772			3,535,839			4,351,439
Income (loss) from operations		(614,833	)		87,607			(2,196,354	)		438,798
Other income (expense):
Amortization of debt discount		(37,948	)		(13,386	)		(82,349	)		(40,177	)
Amortization of debt expense		(68,384	)		(27,081	)		(152,175	)		(81,241	)
Financing Costs		(21,441	)		-			(47,918	)		-
Change in fair value of common stock warrants		19,710			130,433			268,767			66,738
Gain on sale of capital asset		-			500			-			500
Proceeds from life insurance policy		-			-			-			300,029
Interest income		420			224			433			418
Interest expense		(126,489	)		(103,155	)		(349,989	)		(302,265	)
Total other income (expense)		(234,132	)		(12,465	)		(363,231	)		(55,998	)
Income (loss) before income taxes		(848,965	)		75,142			(2,559,585	)		382,800
Income tax expense (benefit)		(303,788	)		(22,289	)		(915,903	)		262,848
Net income (loss)	$	(545,177	)	$	97,431		$	(1,643,682	)	$	119,952
Basic income (loss) per common share	$	(0.19	)	$	0.04		$	(0.59	)	$	0.05
Diluted income (loss) per common share	$	(0.19	)	$	0.04		$	(0.59	)	$	0.04
Weighted average shares outstanding:
Basic		2,912,516			2,652,864			2,776,643			2,650,032
Diluted		2,912,516			2,706,078			2,776,643			2,718,720

See accompanying notes to condensed consolidated financial statements.

4

TEL-INSTRUMENT ELECTRONICS CORP

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine months ended
	December 31, 2012			December 31, 2011
				(Restated)
Cash flows from operating activities:
Net income (loss)	$	(1,643,682	)	$	119,952
Adjustments to reconcile net income (loss) to net cash provided by     (used in) operating activities:
Deferred income taxes		(919,814	)		261,572
Depreciation and amortization		160,140			117,376
Allowance for bad debts		-			(1,200	)
Provision for inventory obsolescence		-			1,971
Gain on sale of asset		-			(500	)
Amortization of debt discount		82,349			40,177
Amortization of debt expense		152,174			81,241
Increase in cash surrender value of life insurance		-			2,011
Proceeds from life insurance policy		-			(300,029	)
Warrants issued in exchange for services		47,918			-
Change in fair value of common stock warrant		(268,767	)		(66,738	)
Non-cash stock-based compensation		62,884			68,324
Changes in assets and liabilities:
Decrease in accounts receivable		1,041,720			817,002
Decrease in unbilled government receivables		728,724			-
Increase in inventories		(1,780,056	)		(817,564	)
Decrease (increase) in prepaid expenses & other		126,381			(66,572	)
Increase in other assets		-			(36,302	)
Increase in accounts payable		1,150,140			876,047
Decrease in accrued payroll, vacation pay & withholdings		(70,661	)		(34,873	)
Decrease in deferred revenues		(13,125	)		(17,436	)
Increase (decrease) increase in progress billings		-			(424,202	)
Decrease in accrued expenses		(527,446	)		(90,025	)
Net cash (used in) provided by operating activities		(1,671,121	)		530,232
Cash flows from investing activities:
Proceeds from the sale of capital asset		-			500
Purchases of equipment		(60,816	)		(149,161	)
Net cash used in investing activities		(60,816	)		(148,661	)
Cash flows from financing activities:
Proceeds from the exercise of stock options		104,430			21,749
Proceeds from the sale of common stock		1,000,002			-
Proceeds from long-term debt		600,000			-
Expenses associated with long-term debt		(111,340	)		-
Repayment of long-term debt		(127,929	)		(158,493	)
Repayment of capitalized lease obligations		(47,627	)		(41,295	)
Proceeds from life insurance policy		-			312,683
Net cash provided by  financing activities		1,417,536			134,644
Net (decrease) increase in cash and cash equivalents		(314,401	)		516,215
Cash and cash equivalents at beginning of period		413,195			123,955
Cash and cash equivalents at end of period	$	98,794		$	640,170
Taxes paid	$	-		$	-
Interest paid	$	261,413		$	269,131
Capitalized lease obligations	$	-		$	254,734

See accompanying notes to condensed consolidated financial statements.

5

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp (the “Company” or “TIC”) as of December 31, 2012, the results of operations for the three and nine months ended December 31, 2012 and December 31, 2011, and statements of cash flows for the nine months ended December 31, 2012 and December 31, 2011.  These results are not necessarily indicative of the results to be expected for the full year.  The financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K.  The March 31, 2012 balance sheet included herein was derived from the audited financial statements included in the Company’s annual report on Form 10-K as of that date.  Accordingly, the financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2012.

Note 2 – Revenue Recognition – Percentage-of-Completion – ITATS (“Intermediate Level TACAN Test Set”) (AN/ARM-206)

Due to the unique nature of the ITATS program, wherein a significant portion of this contract will not be delivered for over a year, revenues under this contract are recognized on a percentage-of-completion basis, which recognizes sales and profit as they are earned, rather than at the time of shipment.  Revenues and profits are estimated using the cost-to-cost method of accounting where revenues are recognized and profits recorded based upon the ratio of costs incurred to estimate of total costs at completion.  The ratio of costs incurred to date to the estimate of total costs at completion is applied to the contract value to determine the revenues and profits.  When adjustments in estimated contract revenues or estimated costs at completion are required, any changes from prior estimates are recognized by recording adjustments in the current period for the inception-to-date effect of the changes on current and prior periods.  The Company also receives progress billings on this program, which is a funding mechanism by the government to assist contractors on long-term contracts prior to delivery.  These progress payments are applied to Unbilled Government Receivables resulting from revenues recognized under percentage-of-completion accounting.  There have been no progress billings or revenues recognized during the nine months ended December 31, 2012 in connection with the ITATS program.

The AN/ARM-206 ITATS program is proceeding well with the enhancements funded by the U.S. Navy last year now finished. The Company has completed final acceptance testing on the initial prototype units and has secured approval on these units in February 2012. The Company is currently undergoing its Production Readiness Review with the U.S. Navy.  The Company currently has orders for 102 units for approximately $5.3 million. It is expected that shipments will commence in the first half of calendar year 2013.

Note 3 – Accounts Receivable, net

The following table sets forth the components of accounts receivable:

	December 31, 2012			March 31, 2012
Government	$	338,924		$	1,272,436
Commercial		349,462			457,670
Less: Allowance for doubtful accounts		(35,470	)		(35,470	)
	$	652,916		$	1,694,636

Note 4 –Inventories, net

Inventories consist of:

	December 31, 2012			March 31, 2012
Purchased parts	$	5,201,484		$	3,452,832
Work-in-process		1,791,992			1,725,395
Finished goods		10,555			45,748
Less: Inventory reserve		(200,000	)		(200,000	)
	$	6,804,031		$	5,023,975

6

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 5 – Loss Per Share

Financial Accounting Standards Board (“FASB”) ASC 260 requires presentation of basic earnings per share (“basic EPS”) and diluted earnings per share (“diluted EPS”).

The Company’s basic income (loss) per common share is based on net income (loss) for the relevant period, divided by the weighted average number of common shares outstanding during the period.  Diluted income per common share is based on net income, divided by the weighted average number of common shares outstanding during the period, including common share equivalents, such as outstanding stock options.  Diluted loss per share for the three and nine months ended December 31, 2012 does not include common stock equivalents, as these stock equivalents would be anti-dilutive.

	Three Months Ended			Three Months Ended
	December 31, 2012			December 31, 2011
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(545,177	)	$	97,431
Weighted-average common shares outstanding		2,912,516			2,652,864
Basic net income (loss) per share attributable to        common stockholders	$	(0.19	)	$	0.04
Diluted net income (loss)  per share computation
Net income (loss) attributable to common stockholders	$	(545,177	)	$	$   97,431
Weighted-average common shares outstanding		2,912,516			2,652,864
Incremental shares attributable to the assumed exercise        of outstanding stock options		-			53,214
Total adjusted weighted-average shares		2,912,516			2,706,078
Diluted net income (loss) per share attributable to        common stockholders	$	(0.19	)	$	0.04

	Nine Months Ended			Nine Months Ended
	December 31, 2012			December 31, 2011
				(Restated)
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(1,643,682	)	$	119,952
Weighted-average common shares outstanding		2,776,643			2,650,032
Basic net income (loss) per share attributable to       common stockholders	$	(0.59	)	$	0.05
Diluted net income (loss) per share computation
Net income (loss) attributable to common stockholders	$	(1,643,682	)	$	119,952
Weighted-average common shares outstanding		2,776,643			2,650,032
Incremental shares attributable to the assumed exercise      of outstanding stock options		-			68,688
Total adjusted weighted-average shares		2,776,643			2,718,720
Diluted net income (loss) per share attributable to       common stockholders	$	(0.59	)	$	0.04

7

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 6 – Long-Term Debt

In September 2010, the Company entered into an agreement with BCA Mezzanine Fund LLP (“BCA”) to loan the Company $2,500,000 in the form of a Promissory Note (the “Note”).  The Company incurred expenses of $541,604 in connection with this loan, including legal fees, investment banking fees and other transaction fees.  These expenses are included as deferred debt expense in the accompanying balance sheet, and these expenses are being amortized over the term of the loan.

The features of the Note are as follows:

(1)   The Note has a term of five (5) years with an annual interest rate of 14% on the outstanding principal amount.  Payments for the first year were interest only and amounted to $28,762 monthly.  In September 2011, the Company began making monthly payments of approximately $69,000 for interest and principal for the remaining term of the loan. BCA had agreed to allow the Company to defer principal payments for the three months ended September 30, 2012. BCA has also agreed to allow the Company to defer principal payments due on October 31 and November 30, 2012. These amounts are deferred until September 2015. BCA has also agreed to allow the Company to defer principal payments due on December 31, 2012 and January 31, 2013 to February 2013.

(2)   At inception, the Company issued BCA  a nine-year warrant for 136,090 shares, based upon 4.5% of the fully-diluted outstanding shares of the Company’s common stock exercisable at $6.70 per share, the average closing price of the common stock over the three days preceding the loan closing on the NYSE-MKT Exchange.  In the event of specific major corporate events or the maturity of the five-year loan, BCA can require the Company to purchase the warrant and warrant shares at the higher of the then Exchange market price less the share exercise price, in the case of the purchase of the warrant, or five times operating income per share. In connection with the warrant issued in conjunction with the issuance of this debt, the Company recorded a debt discount and warrant liability, which is being marked to fair value at the end of each period (see Note 10 to Notes to the Condensed Consolidated Financial Statements).  The debt discount is being amortized over the life of the loan.

(3)   Loan provisions also contain customary representations and warranties.

(4)   BCA has a lien on all of the Company’s assets.  In February 2011, BCA agreed to release part of its lien on Company assets to the U.S. Government to allow for progress billings up to $1,000,000.

(5)   The Company was required to pay prepayment fees if the Company decided to prepay a portion of the principal amount during the first two years of the loan. The Company may now prepay a portion of the principal amount without any prepayment penalty.  Each payment must be not less than $25,000 or multiples of $25,000 in excess thereof.

(6)   Upon the occurrence of a Change of Control (as defined in the Agreement) or within five (5) Business Days of an O’Hara Life Insurance Realization Event (as defined in the Agreement), the Company shall, in each case at the election of BCA, prepay by wire transfer the entire outstanding principal amount of the Note in accordance with the redemption prices (the “Mandatory Redemption Prices”) set forth below (expressed as a percentage of the outstanding principal amount being prepaid and shall pay 103% in the first year of the loan, 102% in the second year of the loan, and 100% thereafter), together with (x) Interest, if any, accrued and unpaid on the outstanding principal amount of the Note so prepaid through the date of such prepayment, (y) all reasonable out-of-pocket costs and expenses (including reasonable fees, charges and disbursements of counsel), if any, associated with such prepayment, and (z) all other costs, expenses and indemnities then payable under this Agreement (such amounts, collectively the “Mandatory Redemption Payment”).  If a Change of Control or O’Hara Life Insurance Realization Event shall occur during any Loan Year set forth below, the Mandatory Redemption Price shall be determined based upon the percentage indicated above for such Loan Year multiplied by the principal amount which is being prepaid.  At the  election of BCA, all or any portion of the Mandatory Redemption Payment may be paid in the form of common stock of the Company in marketable condition in lieu of cash and to the extent available and to the extent not restricted by any SBIC Regulations.  In the event BCA makes the election contemplated by the immediately preceding sentence, the Company shall issue to BCA that number of shares having an aggregate Current Market Price as of such issuance date equal to that portion of the Mandatory Redemption Payment subject to such election.

(7)   The Note contains a number of affirmative and negative covenants which restrict our operations.  The BCA agreement contains a number of affirmative and negative covenants. For the quarter ended December 31, 2012, the Company was not in compliance with four covenants related to maintaining agreed upon financial ratios for fixed charges, leverage and debt service as well as a requirement for earnings before interest, taxes, depreciation and amortization (EBITDA) However, the Company received a waiver from BCA on each of the above mentioned covenants.   

(8)   The Company and BCA have amended certain provisions to certain restrictions.

8

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 6 – Long-Term Debt (continued)

In consideration for the waiver for non-compliance of the financial covenants at March 31, 2012, BCA received warrants to purchase 20,000 shares of the Company’s common stock. The common stock underlying the warrant are exercisable at a price of $3.35 per share and the warrants expire on September 10, 2019. Determining the warrant value to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrant is calculated using the Black-Scholes valuation model. The value of the warrant was charged to financing costs in the accompanying statement of operations in the amount of $26,477 for the nine months ended December 31, 2012 (see Note 10).

In consideration for the waiver for non-compliance of the financial covenants as September 30, 2012 and for the deferral of principal payments due on October 31 and November 30, 2012 to the end of the term of the loan (maturity), BCA received warrants to purchase 20,000 shares of the Company’s common stock. The common stock underlying the warrants are exercisable at a price of $3.56 per share and the warrant expire on September 10, 2019. Determining the warrant value to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrant is calculated using the Black-Scholes valuation model. The value of the warrant was charged to financing costs in the accompanying statement of operations in the amount of $21,441 for the three and nine months ended December 31, 2012 (see Note 10).

In consideration for the waiver for non-compliance of the financial covenants as December 31, 2012 and for the deferral of principal payments due on December 31, 2012 and January 31, 2013, BCA received warrants to purchase 20,000 shares of the Company’s common stock. The common stock underlying the warrant is exercisable at a price of $3.58 per share and the warrants expire on September 10, 2019. Fair value of the warrant is calculated using the Black-Scholes valuation model. The value of the warrant is $23,714. In addition, the Company agreed to pay an additional closing fee of 1% of the original principal in the amount of $25,000.

On July 26, 2012 the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a private investor (the “Private Investor”).  Pursuant to the terms of the Purchase Agreement, the Company issued (i) a senior secured promissory note in favor of the Private Investor in the aggregate principal amount of $600,000, approximately $489,000 net of expenses, accruing interest at a rate of 14% per annum and (ii) a common stock purchase warrant to purchase 50,000 shares of the Company’s common stock, par value $0.10 per share. The Note, together with all unpaid interest and principal is due on March 31, 2013.  The common stock underlying the warrant is exercisable at a price of $3.35 per share and the warrant expires on September 10, 2019. In conjunction with the Purchase Agreement the Company entered into an (i) Investor Rights Agreement, (ii) Securities Agreement, (iii) Intercreditor Agreement and (iv) Subordination Agreement. The Company reported the foregoing on its Current Report on Form 8-K on August 3, 2012.

In connection with the warrant issued in conjunction with this debt, the Company recorded a debt discount and warrant liability, which is being marked to fair value at the end of each period (see Note 10 to Notes to the Condensed Consolidated Financial Statements).  The Company adopted the guidance of ASC 815, which requires that we mark the value of our warrant liability (see Note 10) to market and recognize the change in valuation in our statement of operations each reporting period. Determining the warrant liability to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrant calculated using the Black-Scholes valuation model was $65,193. The corresponding debt discount is being amortized over the life of the loan.

The new promissory note, dated July 26, 2012 with the Private Investor, contains a number of affirmative and negative covenants which restrict our operations.  The agreement contains a number of affirmative and negative covenants. For the quarter ended December 31, 2012, the Company was not in compliance with four covenants related to maintaining agreed upon financial ratios for fixed charges, leverage and debt service as well as a requirement for earnings before interest, taxes, depreciation and amortization (EBITDA).  However, the Company received a waiver on each of the above mentioned covenants.

Note 7 – Stock Options

The Company adopted FASB ASC 718, utilizing the modified prospective method.  FASB ASC 718 requires the measurement of stock-based compensation based on the fair value of the award on the date of grant.  Under the modified prospective method, the provisions of ASC 718 apply to all awards granted after the date of adoption.  The Company recognizes compensation cost on awards on a straight-line basis over the vesting period, typically four years.  As a result of adopting ASC 718, operations were charged $16,607 and $62,884 for three months and nine months ended December 31, 2012, respectively, as compared to $21,830 and $68,324 for the three and nine months ended December 31, 2011, respectively. The Company estimates the fair value of each option using the Black Scholes option-pricing model with the following weighted-average assumptions: expected dividend yield of 0.0%, risk-free interest rate of 0.86% to 1.08%, volatility at 36.07% to 36.63% of the Company’s stock, and an expected life of 5 years for options granted for the nine months ended December 31, 2011. The Company estimates forfeiture rate based on historical data.  Based on an analysis of historical information, the Company applied a forfeiture rate of 8%. The Company did not grant any options during the nine months ended December 31, 2012.

9

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 8 – Segment Information

In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial.  There are no inter-segment revenues.

The Company is organized primarily on the basis of its avionics products.  The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors.  The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops.  The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments.

Management evaluates the performance of its segments and allocates resources to them based on gross margin.  The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific.  As a result, all operating expenses are not managed on a segment basis.  Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level.

The table below presents information about reportable segments within the avionics business for the three and nine month periods ending December 31, 2012 and 2011:

Three Months Ended  December 31, 2012	Avionics  Government		Avionics  Commercial		Avionics  Total			Corporate  Items			Total
Net sales		1,828,941		521,079		2,350,020			-			2,350,020
Cost of Sales		1,480,584		416,068		1,896,652			-			1,896,652
Gross Margin		348,357		105,011		453,368			-			453,368
Engineering, research, and development						481,055						481,055
Selling, general and administrative						264,627			322,519			587,146
Amortization of debt discount									37,948			37,948
Amortization of debt expense									68,384			68,384
Financing costs									21,441			21,441
Change in fair value of common stock warrants									(19,710	)		(19,710	)
Interest expense, net									126,069			126,069
Total expenses						745,682			556,651			1,302,333
Loss before income taxes						(292,314	)		(556,651	)		(848,965	)

Three Months Ended December 31, 2011	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales		3,163,220		510,015		3,673,235		-			3,673,235
Cost of Sales		1,841,826		386,030		2,227,856		-			2,227,856
Gross Margin		1,321,394		123,985		1,445,379		-			1,445,379
Engineering, research, and development						633,136					633,136
Selling, general and administrative						358,388		366,248			724,636
Amortization of debt discount						-		13,386			13,386
Amortization of debt expense						-		27,081			27,081
Financing costs						-		-			-
Change in fair value of common stock warrants						-		(130,433	)		(130,433	)
Interest expense, net						-		102,431			102,431
Total expenses						991,524		378,713			1,370,237
Income (loss) before income taxes					$	453,855	$	(378,713	)	$	75,142

10

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 8 – Segment Information (Continued)

Nine Months Ended  December 31, 2012	Avionics  Government		Avionics  Commercial		Avionics  Total			Corporate  Items			Total
Net sales		4,226,451		1,695,807		5,922,258			-			5,922,258
Cost of Sales		3,051,873		1,530,900		4,582,773			-			4,582,773
Gross Margin		1,174,578		164,907		1,339,485			-			1,339,485
Engineering, research, and development						1,608,459			-			1,608,459
Selling, general and administrative						891,764			1,035,616			1,927,380
Amortization of debt discount									82,349			82,349
Amortization of debt expense									152,175			152,175
Financing costs									47,918			47,918
Change in fair value of common stock warrants									(268,767	)		(268,767	)
Proceeds from life insurance									-			-
Interest expense, net									349,556			349,556
Total expenses						2,500,223			1,398,847			3,899,070
Loss before income						(1,160,738	)		(1,398,847	)		(2,559,585	)

Nine Months Ended  December 31, 2011	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales		9,470,103		1,867,697		11,337,800		-			11,337,800
Cost of Sales		5,342,873		1,204,690		6,547,563		-			6,547,563
Gross Margin		4,127,230		663,007		4,790,237		-			4,790,237
Engineering, research, and development						2,160,107		-			2,160,107
Selling, general and administrative						1,046,231		1,145,101			2,191,332
Amortization of debt discount						-		40,177			40,177
Amortization of debt expense						-		81,241			81,241
Financing costs						-		-			-
Change in fair value of common stock warrants						-		(66,738	)		(66,738	)
Proceeds from life insurance						-		(300,029	)		(300,029	)
Interest (income) expense, net						-		301,347			301,347
Total expenses						3,206,338		1,201,099			4,407,437
Income (loss) before income taxes					$	1,583,899	$	(1,201,099	)	$	382,800

11

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 9 – Income Taxes

The Company adopted FASB ASC 740-10, Accounting for Uncertainty in Income Taxes, effective April 1, 2007.  ASC 740-10 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions.  The Company does not have any unrecognized tax benefits.

The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset in the accompanying December 31, 2012 and March 31, 2012 condensed consolidated balance sheets.  Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse (See Critical Accounting Policies – Income Taxes).

Note 10 – Fair Value Measurements

FASB ASC 820-10, Fair Value Measurements and Disclosures defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and expands disclosures about fair value measurements.

As defined in ASC 820-10, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price).  The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique.  These inputs can be readily observable, market corroborated, or generally unobservable.  The Company classifies fair value balances based on the observability of those inputs. ASC 820-10 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy defined by ASC 820-10 are as follows:

·   Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.  Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

·   Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.  Level 2 includes those financial instruments that are valued using models or other valuation methodologies.  These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.  Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.  Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

·   Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources.  These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

The valuation techniques that may be used to measure fair value are as follows:

·   Market approach — Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

·   Income approach — Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method.

·   Cost approach — Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).

12

   TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 10 – Fair Value Measurements (continued)

The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility reflect currently available terms and conditions for similar debt.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of December 31 2012 and March 31, 2012.  As required by FASB ASC 820-10, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.

December 31, 2012	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		200,634		200,634
Total Liabilities	$	-	$	-	$	200,634	$	200,634

March 31, 2012	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		355,290		355,290
Total Liabilities	$	-	$	-	$	355,290	$	355,290

The Company adopted the guidance of ASC 815, which requires that we mark the value of our warrant liability (see Note 6) to market and recognize the change in valuation in our statement of operations each reporting period. Determining the warrant liability to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrants is calculated using the Black-Scholes valuation model.

The following table provides a summary of the changes in fair value of our Level 3 financial liabilities from March 31, 2012 through December 31, 2012 as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to the liability held at December 31, 2012:

Level 3 Reconciliation	Beginning at beginning of period		Gains and losses for the period (realized and unrealized)			Purchases, issuances, sales and settlements, net		Transfers in or out of Level 3		Balance at the end of period
Warrant liability		355,290		(268,767	)		114,111				200,634
Total Liabilities	$	355,290	$	(268,767	)	$	114,111	$	-	$	200,634

(1)  $66,193 recorded as deferred debt expense and $47,918 recorded as financing costs

13

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 10 – Fair Value Measurements (continued)

The common stock warrants were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign corporation.  The warrants do not qualify for hedge accounting, and, as such, all changes in the fair value of these warrants are recognized as other income/expense in the statement of operations until such time as the warrants are exercised or expire.  Since these common stock warrants do not trade in an active securities market, the Company recognizes a warrant liability and estimates the fair value of these warrants using the Black-Scholes options model using the following assumptions:

Values at Inception

Date of Warrant	Expiration  Date		Number of Warrants		Exercise  Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free  Interest Rate			Warrant  Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	6.70		28.51	%		9		2.81	%	$	267,848
09-10-2010		09-10-2015		10,416	$	6.70	$	6.70		28.51	%		5		1.59	%	$	13,808
07-26-2012		09-10-2019		50,000	$	3.35	$	3.90		42.04	%		7		0.94	%	$	66,193
07-26-2012		09-10-2019		20,000	$	3.35	$	3.90		42.04	%		7		0.94	%	$	26,477
11-20-2012		09-10-2019		20,000	$	3.56	$	3.50		42.45	%		6.83		1.09	%		21,441

Values at March 31, 2012

Date of  Warrant	Expiration  Date		Number of Warrants		Exercise Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free Interest Rate			Warrant Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	6.33		53.19	%		7.45		2.23	%	$	338,116
09-10-2010		09-10-2015		10,416	$	6.70	$	6.33		53.19	%		3.45		2.23	%	$	17,174

Values at December 31, 2012

Date of  Warrant	Expiration Date		Number of Warrants		Exercise  Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free Interest Rate			Warrant Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	3.65		42.07	%		6.70		1.18	%	$	93,222
09-10-2010		09-10-2015		10,416	$	6.70	$	3.65		42.07	%		2.70		0.36	%	$	2,572
07-26-2012		09-10-2019		50,000	$	3.35	$	3.65		42.07	%		6.58		1.18	%	$	58,612
07-26-2012		09-10-2019		20,000	$	3.35	$	3.65		42.07	%		6.58		1.18	%	$	23,444
11-20-2012		09-10-2019		20,000	$	3.56	$	3.65		42.07	%		6.75		1.18	%	$	22,784

The volatility calculation was based on the 36 months for the Company’s stock price prior to the measurement date, utilizing January 1, 2010 as the initial period, as the Company believes that this is the best indicator of future performance, and the source of the risk free interest rate is the US Treasury rate related to 10 year notes.  The exercise price is per the agreement, the fair market value is the closing price of our stock on the date of measurement, and the expected life is based on management’s current estimate of when the warrants will be exercised.  All inputs to the Black-Scholes options model are evaluated each reporting period.

Note 11 – Reclassifications

Certain prior year and period amounts have been reclassified to conform to the current period presentation.

14

TEL-INSTRUMENT ELECTRONICS CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 12 – Litigation

On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court, Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army (the “Award”), to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5. Aeroflex’s petition alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with its business relationship; conspired to harm Aeroflex and tortiously interfered with its contract and seeks injunctive relief and damages. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Award to the Company, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”). In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the Army Contracts Attorney and the Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed Aeroflex proprietary technology in winning the Award, and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.

In December 2009, the Kansas district court dismissed on jurisdiction grounds the Aeroflex Action. Aeroflex appealed this decision.  In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the district court for further proceedings. The district court has established discovery deadlines and the case is set for trial on January 14, 2014.  Tel is optimistic as to the outcome of this litigation.  However, the outcome of any litigation is unpredictable and an adverse decision in this matter could have a material adverse effect on our financial condition, results of operations or liquidity. 

Note 13 – Restatement

The state and local deferred tax provision was increased for the year ended March 31, 2012 as a result of a change in New Jersey tax law which, in substance, lowered the New Jersey tax rate, which resulted in lowering the carrying value of the New Jersey net deferred tax assets and net income by $394,604 and $256,644, respectively. The New Jersey tax law change was effective for the first quarter of fiscal year 2012, ending June 30, 2011. As such, the accompanying statement of operations has been restated to reflect the adjustment to net income in the first quarter of fiscal year 2012. This change has also been reported in the Company’s report on Form 8-K filed on July 13, 2012. The Company did not lose any future benefit, and the result is such that the Company will have lower NJ tax expense in the future.

Note 14 – Subscription Agreements

On September 26, 2012, the Company secured an equity purchase commitment for up to $500,000 in total from the Chief Executive Officer, a director and an affiliate to the Company to be called upon at the Company’s discretion. The stock subscription agreements provide for the sale of up to $500,000 of newly issued restricted shares at a price of $3.60 per share, the closing average price of the Company’s common stock following the signing of the individual stock subscription agreements. All of the $500,000 has been called upon by the Company as of December 31, 2012, and the Company issued 138,890 shares of restricted stock in exchange for this amount to the three investors.   This financing will be used for general business purposes.

The price was determined to be fair by a Special Valuation Committee of the Board, composed of Messrs. Robert H. Walker and Robert A. Rice, who did not participate in this share purchase.

In November 2012, the Company received $500,000 from an investment group in exchange for 149,254 shares of newly issued Company common stock at a price of $3.35 per share. These funds will be used for general operating purposes.

Note 15 – New Accounting Pronouncements

For the nine months ended December 31, 2012, there have been no significant accounting pronouncements or changes in accounting pronouncements that have become effective that are expected to have a material impact on the Company’s financial position, operations or cash flows.

15

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward Looking Statements

This quarterly report on Form 10-Q and other reports filed by the Company from time to time with the SEC contain or may contain forward-looking statements (collectively the “Filings”) and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management.  Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof.  When used in the Filings, the words “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan”, or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements.  Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks contained in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended March 31, 2012, filed with the SEC on July 16, 2012 relating to the Company’s industry, the Company’s operations and results of operations, and any businesses that the Company may acquire.  Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements.  Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”).  These accounting principles require us to make certain estimates, judgments and assumptions.  We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made.  These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented.  Our financial statements would be affected to the extent there are material differences between these estimates and actual results.  In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application.  There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result.  The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

Overview

The Company recorded sharply reduced revenues and a significant loss for the nine months ended December 31, 2012 due mainly to the limited production on the CRAFT 708 program and delays in securing a production release on the TS-4530A program from the Army.

The production delays on the CRAFT and TS-4530A programs have negatively impacted the Company’s cash flow. As such, the Company secured additional short-term financing in July for $600,000, received a progress payment from the government on the CRAFT program for approximately $990,000 (which has been repaid as of December 31, 2012), received an equity purchase for $500,000 from the Company’s Chief Executive Officer, a director and an affiliate to the Company, and in November 2012 received approximately $500,000 from an investment group in exchange for approximately 149,250 shares of newly issued common stock. Based on expected production releases, the Company believes that it will have adequate liquidity, and backlog to fund operating plans for at least the next twelve months.  Currently, the Company has no material future capital expenditure requirements.

If the Company is unable to obtain production releases within a reasonable period of time and/or our vendors or lenders begin to pursue legal action demanding payments, it would result in a material adverse effect on the Company’s operations and its ability to pay its obligations. As such, the Company may need to pursue additional sources of financing and/or additional progress payments.

CRAFT “Communications/Navigation (COMM/NAV) Radio Frequency (RF) Avionics Flight line Tester”) (AN/USM-708 and AN/USM-719) with the U.S. Navy

In March 2012, the U.S. Navy placed a temporary hold on CRAFT 708 production shipments to correct issues discovered in prior CRAFT 719 deliveries and incorporate the final AIMS approved software configuration which includes several product enhancements. The U.S. Navy requested that the Company perform a Root Cause Analysis on the issues seen in the CRAFT 719 units. On June 14, 2012, the U.S. Navy, based upon observations at the Company’s facility, indicated that the Company’s Root Cause Analysis was adequate and that the Company has made progress in addressing the quality issues found in the production of the CRAFT units. As a result, the U.S. Navy granted the Company permission to resume limited production, a combination of new units and rework units. The U.S. Navy continued to monitor the production of these units.

16

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Overview (continued)

The U.S. Navy has been satisfied with the production results, and, as such, has approved a full rate production release for this program, which will help the Company’s cash flow. As of December 31, 2012, the Company had approximately $10,400,000 in orders remaining for this program.

The issues identified with the CRAFT units required that all CRAFT 719 and CRAFT 708 units be updated with revised software and that TIC will revalidate all of the 460 ship-in-place units at TIC before they are shipped to the customer. (These ship-in-place units had been built and paid for by the U.S. Navy but could not be shipped to the field due to regulatory restrictions.)  TIC and the U.S. Navy have finalized the upgraded test procedure for these units. The test procedure needed to be upgraded to reflect the extensive changes to the units over the last few years. The U.S. Navy has also verified and approved these new test procedures and reviewed TIC’s quality assurance procedures. The U.S. Navy has also indicated that additional foreign military sales (“FMS”) are expected for the CRAFT product, and the Company is also actively quoting orders for other customers. The CRAFT unit recently received a Stage Four approval from the FAA, and the Company will shortly begin full-rate deployment to the U.S. Navy.

TS-4530 IFF test set with the U.S. Army Aviation and Missile Command

The TS-4530A program has been essentially complete from a design standpoint. The Mode 5 conversion kits and new IFF test sets will incorporate the Company’s proprietary electronics and IFF technology in addition to Mode S Enhanced Surveillance (”EHS”) and Automatic Dependent Surveillance - Broadcast (“ADS-B”) test functionality. In August 2012 the U.S. Army completed its production assurance review. In February 2013, this product successfully completed final testing conducted by the Department of Defense (DOD) AIMS Program Office to approve its TS-4530A Flight Line Test Set authorizing its use for Mark XIIA IFF (“Identification Friend and Foe”), Mode S (ELS/EHS/ADS-B) and TCAS systems. This represents an important event with respect to entering full rate production phase of this program. The Company still needs to pass the Mode S (ELS/EHS/ADS-B) test to obtain final approval, but the Company is expecting an interim approval with a waiver for the Mode S test. TIC and the U.S. Army are working together to secure timing for a production release for this program. The Company expects to secure this interim approval before the end of the fiscal year ended March 31, 2013. The TS-4530A program is a critical program with almost $20,000,000 of booked production orders which will help drive TIC’s revenue growth and profitability.

ITATS (“Intermediate Level TACAN Test Set”) (AN/ARM-206) with the U.S. Navy

The AN/ARM-206 ITATS program is proceeding well with the enhancements funded by the U.S. Navy last year now finished. The Company has completed final acceptance testing on the initial prototype units and has secured approval on these units in February 2013. The Company has also completed its Production Readiness Review with the U.S. Navy.  The Company currently has orders for 102 units for approximately $5.3 million. It is expected that shipments will commence in the first half of calendar year 2013.

At December 31, 2012, the Company’s backlog was approximately $36,915,000 as compared to approximately $44,790,000 at December 31, 2011.

Results of Operations

Sales

For the three and nine months ended December 31, 2012, sales decreased $1,323,215 (36.0%) and $5,415,542 (47.8%), respectively, to $2,350,020 and $5,922,258 for the three and nine months ended December 31, 2012 as compared to $3,673,235 and $11,337,800 for the same periods in the prior year.

Avionics Government sales decreased $1,334,279 (42.2%) and $5,243,652 (55.4%), respectively, to $1,828,941 and $4,226,451 for the three and nine months December 31, 2012, as compared to $3,163,220 and $9,470,103 for the same periods last year.  For the three months ended December 31, 2012, this decrease is attributed to lower sales on the CRAFT program (AN/USM-708 and AN/USM-719) as a result of the temporary hold on CRAFT production shipments to correct issues discovered in prior CRAFT 719 deliveries and incorporate the final AIMS approved software configuration which includes several product enhancements. Additionally, sales decreased as a result of lower sales related to the TS-4530A program.   For the nine months ended December 31, 2012, the decrease in Avionics Government sales is due mainly to a temporary hold in CRAFT 708 production shipments as well as lower sales related to the TS-4530A program and the TR-100 for which the Company delivered on an Air Force program last year.

Commercial sales increased $11,664 (2.2%) to $521,079 for the three months ended December 31, 2012 as compared to $510,015 for the three months ended December 31, 2011. This increase is mostly due to the timing of the deliveries and is not considered to be a trend.  Commercial sales decreased $171,890 (9.2%) to $1,695,807 for the nine months ended December 31, 2012, as compared to $1,867,697 in the same period in the prior year.   For the nine months ended December 31, 2012, this decrease in sales is due to lower sales of the TR-220. This decrease is due to economic conditions in the commercial market which remains depressed. 

17

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued)

Results of Operations (continued)

Gross Margin

Gross margin decreased $992,011 (68.6%) and $3,450,752 (72.0%), respectively to $453,368 and $1,339,485 for the three and nine months ended December 31, 2012 as compared to $1,445,379 and $4,790,237 for the same periods in the prior fiscal year.  Gross profit was materially affected by the lower sales volume due to the temporary hold in CRAFT 708 production shipments and the delay in securing a production release on the TS-4530A program.  The gross margin percentage for the three months ended December 31, 2012 was 19.3%, as compared to 39.3% for the three months ended December 31, 2011.  The gross margin percentage for the nine months ended December 31, 2012 was 22.6%, as compared to 42.3%, for the nine months ended December, 2011.

Operating Expenses

Selling, general and administrative expenses decreased $137,490 (19.0%) to $587,146 for the three months ended December 31, 2012, as compared to $724,636 for the three months ended December 31, 2011.  This decrease is primarily attributed to lower personnel costs, outside commissions and travel expenses. Selling, general and administrative expenses decreased $263,952 (12.0%) to $1,927,380 for the nine months ended December 31, 2012, as compared to $2,191,332 for the nine months ended December 31, 2011.  This decrease is attributed mainly to lower personnel costs, marketing consulting, and travel expenses.

Engineering, research and development expenses decreased $152,081 (24.0%) and $551,648 (25.5%), respectively, to $481,055 and $1,608,459 for the three and nine months ended December 31, 2012 as compared to $633,136 and $2,160,107 for the three and nine months ended December 31, 2011, primarily as a result of a decrease in salaries and consulting fees as a result of the Company finalizing the engineering efforts on the CRAFT and TS-4530A programs.

Other Income (Expense), Net

For the three months ended December 31, 2012, total other expense was $234,132, as compared to other expense of $12,465 for the three months ended December 31, 2011. This increase is the result of higher interest expense and the amortization related to debt expenses. Additionally, for the three months ended December 31, 2012, the Company recorded a gain of $19,710 on the valuation of common stock warrants as compared to a gain of $130,433 for the three months ended December 31, 2011.  For the nine months ended December 31, 2012, the Company's total other expense was $363,231 as compared to other expense of $55,998 for the nine months ended December 31, 2011. For the nine months ended December 31, 2012, the Company recorded a gain on valuation of the common stock warrants of $268,767 as compared to a gain of $66,738 for the nine months ended December 31, 2011. The Company also reported higher interest and amortization expense for this period. This was offset partially by the proceeds from a life insurance policy during the nine months ended December 31, 2011 in the amount of $300,029.

Income (Loss) before Income Taxes

As a result of the above, the Company recorded a loss before income taxes of $848,965 for the three months ended December 31, 2012, as compared to income before taxes of $75,142 for the three months ended December 31, 2011.  The Company also recorded a loss before income taxes of $2,559,585 for the nine months ended December 31, 2012, as compared to income before taxes of $382,800 for the nine months ended December 31, 2011.  

Income Taxes

For the nine months December 31, 2012, the Company recorded an income tax benefit of $915,903 as compared to an income tax provision of $262,848 for the nine months ended December 31, 2011.  For the nine months ended December 31, 2012 the amount represents the statutory federal and state tax rate on the Company’s loss before taxes.  The state and local deferred tax provision was increased for the year ended March 31, 2012 as a result of a change in New Jersey tax law which, in substance, lowered the New Jersey tax rate, which resulted in lowering the carrying value of the New Jersey net deferred tax assets and net income by $394,604 and $256,644, respectively. The New Jersey tax law change was effective for the first quarter of fiscal year 2012, ending June 30, 2011. As such, the nine months ended December 31, 2011 statement of operations included herein has been restated to reflect the adjustment to the income tax provision and net income. The change has also been reported on Form 8-K. The Company did not lose any future benefit, and the result is such that the Company will have lower NJ tax expense in the future.  

18

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued)

Net Income (Loss)

As a result of the above, the Company recorded a net loss of $545,177 for the three months ended December 31, 2012, as compared to net income of $97,431 for the three months ended December 31, 2011. The Company also recorded a net loss of $1,643,682 for the nine months ended December 31, 2012, as compared to net income of $119,952 for the nine months ended December 31, 2011

Liquidity and Capital Resources

December 31, 2012, the Company had net working capital of $2,747,693 as compared to $4,522,111 at March 31, 2012. This change is primarily the result of the reduction in accounts receivable as a result of the lower sales.

During the nine months ended December 31 2012, the Company’s cash balances decreased by $314,401 to $98,794.  The Company’s principal sources and uses of funds were as follows:

Cash provided by/used in operating activities.For the nine months ended December 31, 2012, the Company used $1,671,121 in cash for operations as compared to providing $530,232 in cash from operations for the nine months ended December 31, 2011.  This decrease is primarily attributed to the lower operating income and increase in inventories.

Cash used in investing activities.  For the nine months ended December 31, 2012, the Company used $60,816 of its cash for investing activities, as compared to $149,161 for the nine months ended December 31, 2011 as result of lower purchases of equipment.

Cash provided by financing activities. Net cash provided by financing activities for the nine months ended December 31, 2012 was $1,417,536, as compared to providing $134,644 for the nine months ended December 31, 2011.  This increase was primarily the result of proceeds from the sale of common stock and proceeds from the issuance of long-term debt.

On July 26, 2012 the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a private investor (the “Private Investor”).  Pursuant to the terms of the Purchase Agreement, the Company issued (i) a senior secured promissory note in favor of the Private Investor in the aggregate principal amount of $600,000, approximately $489,000 net of expenses, accruing interest at a rate of 14% per annum and (ii) a common stock purchase warrant to purchase 50,000 shares of the Company’s common stock, par value $0.10 per share. The Note, together with all unpaid interest and principal is due on March 31, 2013.  The common stock underlying the warrant is exercisable at a price of $3.35 per share and the warrant expires on September 10, 2019. In conjunction with the Purchase Agreement the Company entered into an (i) Investor Rights Agreement, (ii) Securities Agreement, (iii) Intercreditor Agreement and (iv) Subordination Agreement. The Company reported the foregoing on its Current Report on Form 8-K on August 3, 2012.

On certain government contracts the Company has been granted progress payments from the government, which allows the Company to bill and collect a portion of its incurred costs on long-term programs before shipment of units, thus helping to fund the costs of these programs. In August 2012, the Company received a progress payment in the amount of $990,000.

On September 26, 2012, the Company secured an equity purchase commitment for up to $500,000 in total from the Chief Executive Officer, a director and an affiliate to the Company to be called upon at the Company’s discretion. The stock subscription agreements provide for the sale of up to $500,000 of newly issued restricted shares at a price of $3.60 per share, the closing average price of the Company’s common stock following the signing of the individual stock subscription agreements. All of the $500,000 has been called upon by the Company as of December 31, 2012, and the Company issued 138,890 shares of restricted stock in exchange for this amount to the three investors.   This financing will be used for general business purposes. The price was determined to be fair by a Special Valuation Committee of the Board, composed of Messrs. Robert H. Walker and Robert Rice, who did not participate in this share purchase.

In November 2012, the Company received $500,000 from an investment group in exchange for 149,254 shares of newly issued Company common stock at a price of $3.35 per share. These funds will be used for general operating purposes.

The Company believes that it has adequate liquidity, based on its backlog, to fund operating plans for at least the next twelve months. If the Company is unable to obtain production releases within a reasonable period of time and/or our vendors or lenders begin to pursue legal action demanding payments, it would result in a material adverse effect on the Company’s operations and its ability to pay its obligations. As such, the Company may need to pursue additional sources of financing and/or additional progress payments.

There was no significant impact on the Company’s operations as a result of inflation for the nine months ended December 31, 2012.  These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2012, filed with the SEC on July 16, 2012.

19

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued)

Off-Balance Sheet Arrangements

As of December 31, 2012, the Company had no off-balance sheet arrangements.

Critical Accounting Policies

Our critical accounting policies are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended March 31, 2012. There have been no changes in our critical accounting policies. Our significant accounting policies are described in our notes to the 2012 consolidated financial statements included in our annual report on Form 10-K for the year ended March 31, 2012.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

We do not hold any derivative instruments and do not engage in any hedging activities.

Item 4.  Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in the reports we file pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our Principal Executive Officer (“PEO”) and Principal Financial Officer (“PFO”), to allow timely decisions regarding required disclosure.  In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can only provide a reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.  Management designed the disclosure controls and procedures to provide reasonable assurance of achieving the desired control objectives.

We carried out an evaluation, under the supervision and with the participation of our management, including our PEO and PFO, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report.  Based upon that evaluation, the PEO and PFO concluded that the Company’s disclosure controls and procedures were not effective due to the fact that the Company did not maintain a sufficient level of resources related to tax accounting thus contributing to a material weakness in internal control. In connection with the preparation of the Company’s financial statements for the fiscal year ended March 31, 2012, the Company re-evaluated certain accounting policies and procedures relating to taxes and determined that it had not properly accounted for a change in the New Jersey tax law N.J.S.A. 54:10A. Such change lowered the Company’s New Jersey tax rate, resulting in lowering the carrying value of the New Jersey net deferred tax assets and increasing the tax provision by $256,644. Such change should have been recorded during the period ended June 30, 2011. The change did not cause the Company to lose any future benefit, and the result is such that the Company will have lower New Jersey tax expenses in the future.  Please see Report on Form 8-K filed with the SEC on July 13, 2012.

Notwithstanding the material weakness in accounting for income taxes, management believes that the condensed consolidated financial statements which are included in this Quarterly Report on Form 10-Q fairly present, in all material respects, the financial position of the Company at December 31, 2012 and March 31, 2012 and their condensed consolidated results of operations  for each of the three and nine months ended December 31, 2012 and 2011, and its cash flows for the nine months ended December 31, 2012 and 2011 in conformity with U.S. generally accepted accounting principles.

Material Weakness and Related Remediation Initiatives

Through the efforts of management, external consultants, and our Audit Committee, we are currently in the process of executing a plan of action to remediate the material weakness identified above.  We expect to complete this action plan during fiscal year 2013.

(b) Changes in Internal Control over Financial Reporting

There have been no changes in our internal controls over financial reporting (as such term is defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act) during the quarter ended December 31, 2012, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

20

PART II – OTHER INFORMATION

Item 1.  Legal Proceedings.

Other than as disclosed in Note 12, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations.  There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our Common Stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

Item 1A.  Risk Factors.

We believe there are no changes that constitute material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2012, filed with the SEC on July 16, 2012.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

On September 26, 2012, the Company secured an equity purchase commitment for up to $500,000 in total from the Chief Executive Officer, a director and an affiliate to the Company to be called upon at the Company’s discretion. The stock subscription agreements provide for the sale of up to $500,000 of newly issued restricted shares at a price of $3.60 per share, the closing average price of Tel’s shares following the signing of the individual stock subscription agreements. All of the $500,000 has been called upon by the Company as of December 31, 2012, and the Company issued 138,890 shares of restricted stock in exchange for this amount to the three investors.   This financing will be used for general business purposes.

The price was determined to be fair by a Special Valuation Committee of the Board, composed of Messrs. Robert H. Walker and Robert A. Rice, who did not participate in this share purchase.

In November 2012, the Company received $500,000 from an investment group in exchange for 149,254 shares of newly issued Company common stock at a price of $3.35 per share. These funds will be used for general operating purposes.

Item 3.  Defaults Upon Senior Securities.

Not applicable.

Item 4.  Mine Safety Disclosures.

Not applicable.

Item 5.  Other Information.

There is no other information required to be disclosed under this item which was not previously disclosed.

21

Item 6.  Exhibits.

Exhibit No.	Description
31.1	Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002*
31.2	Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002*
32.1	Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.INS	XBRL Instance Document**
101.SCH	Taxonomy Extension Schema Document**
101.CAL	Taxonomy Extension Calculation Linkbase Document**
101.DEF	Taxonomy Extension Definition Linkbase Document**
101.LAB	Taxonomy Extension Label Linkbase Document**
101.PRE	Taxonomy Extension Presentation Linkbase Document**

* filed herewith

** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934

22

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TEL-INSTRUMENT ELECTRONICS CORP.
Date: February 19, 2013	By:	/s/ Jeffrey C. O’Hara
		Name: Jeffrey C. O’Hara
		Title:  Chief Executive Officer            Principal Executive Officer

Date: February 19, 2013	By:	/s/ Joseph P. Macaluso
		Name: Joseph P. Macaluso
		Title:  Principal Financial Officer            Principal Accounting Officer

23

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Jeffrey C. O’Hara, certify that:

1.	I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
4.	Along with the Principal Financial Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b)	Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 19, 2013	By:	/s/ Jeffrey C. O’Hara
		Jeffrey C. O’Hara
		Principal Executive Officer Tel-Instrument Electronics Corp

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Joseph P. Macaluso, certify that:

1.	I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
4.	Along with the Principal Executive Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b)	Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 19, 2013	By:	/s/ Joseph P. Macaluso
		Joseph P. Macaluso
		Principal Financial Officer Tel-Instrument Electronics Corp

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Tel-Instrument Electronics Corp (the “Company”), on Form 10-Q for the quarter ended December 31, 2012, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Jeffrey C. O’Hara, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 19, 2013	By:	/s/ Jeffrey C. O’Hara
		Jeffrey C. O’Hara
		Principal Executive Officer Tel-Instrument Electronics Corp

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Tel-Instrument Electronics Corp (the “Company”), on Form 10-Q for the quarter ended December 31, 2012, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Joseph P. Macaluso, Principal Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 19, 2013	By:	/s/ Joseph P. Macaluso
		Joseph P. Macaluso
		Principal Financial Officer Tel-Instrument Electronics Corp

XML

Note 14 - Subscription Agreements (Detail) (USD $)	9 Months Ended
	Dec. 31, 2012
Equity Purchase Commitment, Value (in Dollars)	$ 500,000
Sale of Stock, Price Per Share (in Dollars per share)	$ 3.60
Stock Issued During Period, Value, Restricted Stock Award, Gross (in Dollars)	$ 500,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross	138,890
Number of Investors	3
Stock Issued During Period, Shares, Issued for Cash	500,000
Stock Issued During Period, Shares, New Issues	149,254
Share Price (in Dollars per share)	$ 3.35

XML

Note 8 - Segment Information (Detail) - Schedule of Segment Reporting, by Segment (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Net sales	$ 2,350,020	$ 3,673,235	$ 5,922,258	$ 11,337,800
Cost of Sales	1,896,652	2,227,856	4,582,773	6,547,563
Gross Margin	453,368	1,445,379	1,339,485	4,790,237
Engineering, research, and development	481,055	633,136	1,608,459	2,160,107
Selling, general and administrative	587,146	724,636	1,927,380	2,191,332
Amortization of debt discount	37,948	13,386	82,349	40,177
Amortization of debt expense	68,384	27,081	152,175	81,241
Financing costs	21,441	0	47,918	0
Change in fair value of common stock warrants	(19,710)	(130,433)	(268,767)	(66,738)
Proceeds from life insurance	0	0	0	(300,029)
Interest (income) expense, net	126,069	102,431	349,556	301,347
Total expenses	1,302,333	1,370,237	3,899,070	4,407,437
Income (loss) before income taxes	(848,965)	75,142	(2,559,585)	382,800
Avionics Gov't [Member]
Net sales	1,828,941	3,163,220	4,226,451	9,470,103
Cost of Sales	1,480,584	1,841,826	3,051,873	5,342,873
Gross Margin	348,357	1,321,394	1,174,578	4,127,230
Engineering, research, and development	0	0	0	0
Selling, general and administrative	0	0	0	0
Amortization of debt discount	0	0	0	0
Amortization of debt expense	0	0	0	0
Financing costs	0	0	0	0
Change in fair value of common stock warrants	0	0	0	0
Proceeds from life insurance			0	0
Interest (income) expense, net	0	0	0	0
Total expenses	0	0	0	0
Income (loss) before income taxes	0	0	0	0
Avionics Comm'l. [Member]
Net sales	521,079	510,015	1,695,807	1,867,697
Cost of Sales	416,068	386,030	1,530,900	1,204,690
Gross Margin	105,011	123,985	164,907	663,007
Engineering, research, and development	0	0	0	0
Selling, general and administrative	0	0	0	0
Amortization of debt discount	0	0	0	0
Amortization of debt expense	0	0	0	0
Financing costs	0	0	0	0
Change in fair value of common stock warrants	0	0	0	0
Proceeds from life insurance			0	0
Interest (income) expense, net	0	0	0	0
Total expenses	0	0	0	0
Income (loss) before income taxes	0	0	0	0
Avionics Total [Member]
Net sales	2,350,020	3,673,235	5,922,258	11,337,800
Cost of Sales	1,896,652	2,227,856	4,582,773	6,547,563
Gross Margin	453,368	1,445,379	1,339,485	4,790,237
Engineering, research, and development	481,055	633,136	1,608,459	2,160,107
Selling, general and administrative	264,627	358,388	891,764	1,046,231
Amortization of debt discount	0	0	0	0
Amortization of debt expense	0	0	0	0
Financing costs	0	0	0	0
Change in fair value of common stock warrants	0	0	0	0
Proceeds from life insurance			0	0
Interest (income) expense, net	0	0	0	0
Total expenses	745,682	991,524	2,500,223	3,206,338
Income (loss) before income taxes	(292,314)	453,855	(1,160,738)	1,583,899
Corporate [Member]
Net sales	0	0	0	0
Cost of Sales	0	0	0	0
Gross Margin	0	0	0	0
Engineering, research, and development	0	0	0	0
Selling, general and administrative	322,519	366,248	1,035,616	1,145,101
Amortization of debt discount	37,948	13,386	82,349	40,177
Amortization of debt expense	68,384	27,081	152,175	81,241
Financing costs	21,441	0	47,918	0
Change in fair value of common stock warrants	(19,710)	(130,433)	(268,767)	(66,738)
Proceeds from life insurance			0	(300,029)
Interest (income) expense, net	126,069	102,431	349,556	301,347
Total expenses	556,651	378,713	1,398,847	1,201,099
Income (loss) before income taxes	$ (556,651)	$ (378,713)	$ (1,398,847)	$ (1,201,099)

XML

Note 10 - Fair Value Measurements (Tables)

9 Months Ended

Dec. 31, 2012

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.

December 31, 2012	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		200,634		200,634
Total Liabilities	$	-	$	-	$	200,634	$	200,634

March 31, 2012	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		355,290		355,290
Total Liabilities	$	-	$	-	$	355,290	$	355,290

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table provides a summary of the changes in fair value of our Level 3 financial liabilities from March 31, 2012 through December 31, 2012 as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to the liability held at December 31, 2012:

Level 3 Reconciliation	Beginning at beginning of period		Gains and losses for the period (realized and unrealized)			Purchases, issuances, sales and settlements, net		Transfers in or out of Level 3		Balance at the end of period
Warrant liability		355,290		(268,767	)		114,111				200,634
Total Liabilities	$	355,290	$	(268,767	)	$	114,111	$	-	$	200,634

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]

Since these common stock warrants do not trade in an active securities market, the Company recognizes a warrant liability and estimates the fair value of these warrants using the Black-Scholes options model using the following assumptions:

Date of Warrant	Expiration  Date		Number of Warrants		Exercise  Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free  Interest Rate			Warrant  Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	6.70		28.51	%		9		2.81	%	$	267,848
09-10-2010		09-10-2015		10,416	$	6.70	$	6.70		28.51	%		5		1.59	%	$	13,808
07-26-2012		09-10-2019		50,000	$	3.35	$	3.90		42.04	%		7		0.94	%	$	66,193
07-26-2012		09-10-2019		20,000	$	3.35	$	3.90		42.04	%		7		0.94	%	$	26,477
11-20-2012		09-10-2019		20,000	$	3.56	$	3.50		42.45	%		6.83		1.09	%		21,441

Date of  Warrant	Expiration  Date		Number of Warrants		Exercise Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free Interest Rate			Warrant Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	6.33		53.19	%		7.45		2.23	%	$	338,116
09-10-2010		09-10-2015		10,416	$	6.70	$	6.33		53.19	%		3.45		2.23	%	$	17,174

Date of  Warrant	Expiration Date		Number of Warrants		Exercise  Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free Interest Rate			Warrant Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	3.65		42.07	%		6.70		1.18	%	$	93,222
09-10-2010		09-10-2015		10,416	$	6.70	$	3.65		42.07	%		2.70		0.36	%	$	2,572
07-26-2012		09-10-2019		50,000	$	3.35	$	3.65		42.07	%		6.58		1.18	%	$	58,612
07-26-2012		09-10-2019		20,000	$	3.35	$	3.65		42.07	%		6.58		1.18	%	$	23,444
11-20-2012		09-10-2019		20,000	$	3.56	$	3.65		42.07	%		6.75		1.18	%	$	22,784

XML

Note 10 - Fair Value Measurements (Detail) - Fair Value Measuements, Valuation Assumptions (USD $)			0 Months Ended	9 Months Ended	12 Months Ended	0 Months Ended	9 Months Ended	12 Months Ended	0 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended
	Dec. 31, 2012	Mar. 31, 2012	Sep. 10, 2010 Warrant Issued 09-10-2010 [Member]	Dec. 31, 2012 Warrant Issued 09-10-2010 [Member]	Mar. 31, 2012 Warrant Issued 09-10-2010 [Member]	Sep. 10, 2010 Warrant Issued 09-10-2010 #2 [Member]	Dec. 31, 2012 Warrant Issued 09-10-2010 #2 [Member]	Mar. 31, 2012 Warrant Issued 09-10-2010 #2 [Member]	Jul. 26, 2012 Warrant Issued 07-26-2010 [Member]	Dec. 31, 2012 Warrant Issued 07-26-2010 [Member]	Jul. 26, 2012 Warrant Issued 07-26-2012 #2 [Member]	Dec. 31, 2012 Warrant Issued 07-26-2012 #2 [Member]	Nov. 20, 2012 Warrant Issued 11-20-2012 [Member]	Dec. 31, 2012 Warrant Issued 11-20-2012 [Member]
Expiration Date			Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2015	Dec. 31, 2015	Dec. 31, 2015	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2019
Number of Warrants (in Shares)			136,920	136,920	136,920	10,416	10,416	10,416	50,000	50,000	20,000	20,000	20,000	20,000
Exercise Price (in Dollars per share)			$ 6.70	$ 6.70	$ 6.70	$ 6.70	$ 6.70	$ 6.70	$ 3.35	$ 3.35	$ 3.35	$ 3.35	$ 3.56	$ 3.56
Fair Value Per Share (in Dollars per share)	$ 3.35		$ 6.70	$ 3.65	$ 6.33	$ 6.70	$ 3.65	$ 6.33	$ 3.90	$ 3.65	$ 3.90	$ 3.65	$ 3.50	$ 3.65
Expected Volatality			28.51%	42.07%	53.19%	28.51%	42.07%	53.19%	42.04%	42.07%	42.04%	42.07%	42.45%	42.07%
Remaining Life in Years			9	6.70	7.45	5	2.70	3.45	7	6.58	7	6.58	6.83	6.75
Risk Free Interest Rate			2.81%	1.18%	2.23%	1.59%	0.36%	2.23%	0.94%	1.18%	0.94%	1.18%	1.09%	1.18%
Warrant Liability (in Dollars)	$ 200,634	$ 355,290	$ 267,848	$ 93,222	$ 338,116	$ 13,808	$ 2,572	$ 17,174	$ 66,193	$ 58,612	$ 26,477	$ 23,444	$ 21,441	$ 22,784

XML

Note 4 - Inventories, net

9 Months Ended

Dec. 31, 2012

Inventory Disclosure [Text Block]

Note 4 –Inventories, net

Inventories consist of:

	December 31, 2012			March 31, 2012
Purchased parts	$	5,201,484		$	3,452,832
Work-in-process		1,791,992			1,725,395
Finished goods		10,555			45,748
Less: Inventory reserve		(200,000	)		(200,000	)
	$	6,804,031		$	5,023,975

XML

Note 5 - Loss Per Share (Detail) - Schedule of Earnings Per Share Reconciliation (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders (in Dollars)	$ (545,177)	$ 97,431	$ (1,643,682)	$ 119,952
Weighted-average common shares outstanding	2,912,516	2,652,864	2,776,643	2,650,032
Incremental shares attributable to the assumed exercise of outstanding stock options	0	53,214	0	68,688
Total adjusted weighted-average shares	2,912,516	2,706,078	2,776,643	2,718,720
Diluted net income (loss) per share attributable to common stockholders (in Dollars per share)	$ (0.19)	$ 0.04	$ (0.59)	$ 0.04
Basic net income (loss) per share attributable to common stockholders (in Dollars per share)	$ (0.19)	$ 0.04	$ (0.59)	$ 0.05

XML

Note 4 - Inventories, net (Detail) - Schedule of Inventory (USD $)	Dec. 31, 2012	Mar. 31, 2012
Purchased parts	$ 5,201,484	$ 3,452,832
Work-in-process	1,791,992	1,725,395
Finished goods	10,555	45,748
Less: Inventory reserve	(200,000)	(200,000)
	$ 6,804,031	$ 5,023,975

XML

Note 6 - Long-Term Debt (Detail) (USD $)	3 Months Ended		9 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended	16 Months Ended	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2012	Sep. 30, 2012 BCA Mezzanine Fund LLP Promissory Note [Member]	Dec. 31, 2012 BCA Mezzanine Fund LLP Promissory Note [Member]	Aug. 31, 2011 BCA Mezzanine Fund LLP Promissory Note [Member]	Dec. 31, 2012 BCA Mezzanine Fund LLP Promissory Note [Member]	Dec. 31, 2012 Prepayment penalty, year 1 [Member]	Dec. 31, 2012 Prepayment penalty, year 2 [Member]	Dec. 31, 2012 Prepayment penalty, after year 2 [Member]	Dec. 31, 2012 Consideration for Waiver of Non-Compliance of Covenants, March 31, 2012 [Member]	Dec. 31, 2012 Consideration for Waiver of Non-Compliance of Covenants, September 30, 2012 [Member]	Dec. 31, 2012 Consideration for Waiver of Non-Compliance of Covenants, December 31, 2012 [Member]	Dec. 31, 2012 Private Investor Securities Purchase Agreement [Member]
Debt Instrument, Face Amount							$ 2,500,000		$ 2,500,000							$ 600,000
Debt Issuance Cost (in Dollars)							541,604
Debt Instrument, Term						5 years
Debt Instrument, Interest Rate, Stated Percentage						14.00%										14.00%
Debt Instrument, Periodic Payment								28,762	69,000
Warrant term							nine
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)							136,090		136,090
Fully-dilutive basis used for the calculation of warrant issuance							4.50%
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)							6.70		6.70
Debt Instrument, Collateral							$1,000,000
Debt Instrument, Payment Terms							The Company was required to pay prepayment fees if the Company decided to prepay a portion of the principal amount during the first two years of the loan. The Company may now prepay a portion of the principal amount without any prepayment penalty.Each payment must be not less than $25,000 or multiples of $25,000 in excess thereof.
Prepayment penalty										103.00%	102.00%	100.00%
Debt Instrument, Covenant Compliance							Company was not in compliance with four covenants related to maintaining agreed upon financial ratios for fixed charges, leverage and debt service as well as a requirement for earnings before interest, taxes, depreciation and amortization (EBITDA) However, the Company received a waiver from BCA on each of the above mentioned covenants.
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted (in Shares)													20,000	20,000	20,000	50,000
Investment Warrants, Exercise Price (in Dollars per share)													$ 3.35	$ 3.56	$ 3.58	$ 3.35
Investment Warrants Expiration Date													Sep. 10, 2019	Sep. 10, 2019	Sep. 10, 2019	Sep. 10, 2019
Financial Services Costs (in Dollars)	21,441	0	47,918	0									26,477	21,441
Warrants and Rights Outstanding	200,634		200,634		355,290										23,714	65,193
Debt Instrument, Increase (Decrease) for Period, Net															25,000
Proceeds from Debt, Net of Issuance Costs			$ 489,000
Share Price (in Dollars per share)	$ 3.35		$ 3.35													$ 0.10

XML

Note 7 - Stock Options (Detail) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			4 years
Share-based Compensation (in Dollars)	$ 16,607	$ 21,830	$ 62,884	$ 68,324
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum				0.86%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum				1.08%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum				36.07%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum				36.63%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term				5 years
Options, Forfeiture Rate				8.00%

XML

Note 3 - Accounts Receivable, net

9 Months Ended

Dec. 31, 2012

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

Note 3 – Accounts Receivable, net

The following table sets forth the components of accounts receivable:

	December 31, 2012			March 31, 2012
Government	$	338,924		$	1,272,436
Commercial		349,462			457,670
Less: Allowance for doubtful accounts		(35,470	)		(35,470	)
	$	652,916		$	1,694,636

XML

Note 8 - Segment Information (Detail)	9 Months Ended
	Dec. 31, 2012
Number of Reportable Segments	2

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2012	Mar. 31, 2012
Current assets:
Cash and cash equivalents	$ 98,794	$ 413,195
Accounts receivable, net	652,916	1,694,636
Unbilled government receivables	1,051,657	1,780,381
Inventories, net	6,804,031	5,023,975
Prepaid expenses and other	93,874	220,255
Deferred debt expense	148,727	108,321
Deferred income tax asset	1,099,169	1,288,631
Total current assets	9,949,168	10,529,394
Equipment and leasehold improvements, net	607,546	706,870
Deferred debt expenses – long-term	183,544	264,784
Deferred income tax asset – non-current	2,057,765	948,489
Other assets	56,872	56,872
Total assets	12,854,895	12,506,409
Current liabilities:
Current portion long-term debt	1,187,534	542,382
Capital lease obligations – current portion	72,023	64,675
Accounts payable	4,373,431	3,223,291
Deferred revenues – current portion	24,426	34,767
Accrued payroll, vacation pay and payroll taxes	369,455	440,116
Accrued expenses	1,174,606	1,702,052
Total current liabilities	7,201,475	6,007,283
Subordinated notes payable-related parties	250,000	250,000
Capital lease obligations	94,607	149,582
Deferred revenues	1,853	4,637
Warrant liability	200,634	355,290
Long-term debt, net of debt discount	1,333,377	1,490,302
Total liabilities	9,081,946	8,257,094
Commitments	0	0
Stockholders' equity:
Common stock, par value $.10 per share, 3,000,639 and 2,684,215 issued and outstanding as of December 31, 2012 and March 31, 2012, respectively	300,061	268,421
Additional paid-in capital	7,057,117	5,921,441
Accumulated deficit	(3,584,229)	(1,940,547)
Total stockholders' equity	3,772,949	4,249,315
Total liabilities and stockholders' equity	$ 12,854,895	$ 12,506,409

XML

Note 1 - Basis of Presentation

9 Months Ended

Dec. 31, 2012

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

Note 1 – Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp (the “Company” or “TIC”) as of December 31, 2012, the results of operations for the three and nine months ended December 31, 2012 and December 31, 2011, and statements of cash flows for the nine months ended December 31, 2012 and December 31, 2011.  These results are not necessarily indicative of the results to be expected for the full year.  The financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K.  The March 31, 2012 balance sheet included herein was derived from the audited financial statements included in the Company’s annual report on Form 10-K as of that date.  Accordingly, the financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2012.

XML

Note 10 - Fair Value Measurements (Detail) - Schedule of Fair Value, Assets and Liabilties Measured on Recurring Basis (USD $)	Dec. 31, 2012	Mar. 31, 2012
Total Assets	$ 0	$ 0
Warrant liability	200,634	355,290
Total Liabilities	200,634	355,290
Fair Value, Inputs, Level 1 [Member]
Total Assets	0	0
Warrant liability	0	0
Total Liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Total Assets	0	0
Warrant liability	0	0
Total Liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
Total Assets	0	0
Warrant liability	200,634	355,290
Total Liabilities	$ 200,634	$ 355,290

XML

Note 4 - Inventories, net (Tables)

9 Months Ended

Dec. 31, 2012

Schedule of Inventory, Current [Table Text Block]

Inventories consist of:

	December 31, 2012			March 31, 2012
Purchased parts	$	5,201,484		$	3,452,832
Work-in-process		1,791,992			1,725,395
Finished goods		10,555			45,748
Less: Inventory reserve		(200,000	)		(200,000	)
	$	6,804,031		$	5,023,975

XML

Note 10 - Fair Value Measurements (Detail) - Fair Value, Level III Reconcilliation (USD $)	9 Months Ended
	Dec. 31, 2012
Balance at begining of period	$ 355,290
Gains and losses for the period (realized and unrealized)	(268,767)
Purchases, Issuances, sales and settlements, net	114,111
Transfers in or out of Level 3	200,634
Warrant Liability [Member]
Balance at begining of period	355,290
Gains and losses for the period (realized and unrealized)	(268,767)
Purchases, Issuances, sales and settlements, net	114,111	[1]
Transfers in or out of Level 3	$ 200,634

[1] $66,193 recorded as deferred debt expense and $47918 recorded as financing cost.

XML

Note 8 - Segment Information (Tables)

9 Months Ended

Dec. 31, 2012

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The table below presents information about reportable segments within the avionics business for the three and nine month periods ending December 31, 2012 and 2011:

Three Months Ended  December 31, 2012	Avionics  Government		Avionics  Commercial		Avionics  Total			Corporate  Items			Total
Net sales		1,828,941		521,079		2,350,020			-			2,350,020
Cost of Sales		1,480,584		416,068		1,896,652			-			1,896,652
Gross Margin		348,357		105,011		453,368			-			453,368
Engineering, research, and development						481,055						481,055
Selling, general and administrative						264,627			322,519			587,146
Amortization of debt discount									37,948			37,948
Amortization of debt expense									68,384			68,384
Financing costs									21,441			21,441
Change in fair value of common stock warrants									(19,710	)		(19,710	)
Interest expense, net									126,069			126,069
Total expenses						745,682			556,651			1,302,333
Loss before income taxes						(292,314	)		(556,651	)		(848,965	)

Three Months Ended December 31, 2011	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales		3,163,220		510,015		3,673,235		-			3,673,235
Cost of Sales		1,841,826		386,030		2,227,856		-			2,227,856
Gross Margin		1,321,394		123,985		1,445,379		-			1,445,379
Engineering, research, and development						633,136					633,136
Selling, general and administrative						358,388		366,248			724,636
Amortization of debt discount						-		13,386			13,386
Amortization of debt expense						-		27,081			27,081
Financing costs						-		-			-
Change in fair value of common stock warrants						-		(130,433	)		(130,433	)
Interest expense, net						-		102,431			102,431
Total expenses						991,524		378,713			1,370,237
Income (loss) before income taxes					$	453,855	$	(378,713	)	$	75,142

Nine Months Ended  December 31, 2012	Avionics  Government		Avionics  Commercial		Avionics  Total			Corporate  Items			Total
Net sales		4,226,451		1,695,807		5,922,258			-			5,922,258
Cost of Sales		3,051,873		1,530,900		4,582,773			-			4,582,773
Gross Margin		1,174,578		164,907		1,339,485			-			1,339,485
Engineering, research, and development						1,608,459			-			1,608,459
Selling, general and administrative						891,764			1,035,616			1,927,380
Amortization of debt discount									82,349			82,349
Amortization of debt expense									152,175			152,175
Financing costs									47,918			47,918
Change in fair value of common stock warrants									(268,767	)		(268,767	)
Proceeds from life insurance									-			-
Interest expense, net									349,556			349,556
Total expenses						2,500,223			1,398,847			3,899,070
Loss before income						(1,160,738	)		(1,398,847	)		(2,559,585	)

Nine Months Ended  December 31, 2011	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales		9,470,103		1,867,697		11,337,800		-			11,337,800
Cost of Sales		5,342,873		1,204,690		6,547,563		-			6,547,563
Gross Margin		4,127,230		663,007		4,790,237		-			4,790,237
Engineering, research, and development						2,160,107		-			2,160,107
Selling, general and administrative						1,046,231		1,145,101			2,191,332
Amortization of debt discount						-		40,177			40,177
Amortization of debt expense						-		81,241			81,241
Financing costs						-		-			-
Change in fair value of common stock warrants						-		(66,738	)		(66,738	)
Proceeds from life insurance						-		(300,029	)		(300,029	)
Interest (income) expense, net						-		301,347			301,347
Total expenses						3,206,338		1,201,099			4,407,437
Income (loss) before income taxes					$	1,583,899	$	(1,201,099	)	$	382,800

XML

Note 2 - Revenue Recognition - Percentage-of-Completion - ITATS ("Intermediate Level TACAN Test Set") (AN/ARM-206)

9 Months Ended

Dec. 31, 2012

Revenue Recognition, Percentage-of-Completion Method [Policy Text Block]

Note 2 – Revenue Recognition – Percentage-of-Completion – ITATS (“Intermediate Level TACAN Test Set”) (AN/ARM-206)

Due to the unique nature of the ITATS program, wherein a significant portion of this contract will not be delivered for over a year, revenues under this contract are recognized on a percentage-of-completion basis, which recognizes sales and profit as they are earned, rather than at the time of shipment.  Revenues and profits are estimated using the cost-to-cost method of accounting where revenues are recognized and profits recorded based upon the ratio of costs incurred to estimate of total costs at completion.  The ratio of costs incurred to date to the estimate of total costs at completion is applied to the contract value to determine the revenues and profits.  When adjustments in estimated contract revenues or estimated costs at completion are required, any changes from prior estimates are recognized by recording adjustments in the current period for the inception-to-date effect of the changes on current and prior periods.  The Company also receives progress billings on this program, which is a funding mechanism by the government to assist contractors on long-term contracts prior to delivery.  These progress payments are applied to Unbilled Government Receivables resulting from revenues recognized under percentage-of-completion accounting.  There have been no progress billings or revenues recognized during the nine months ended December 31, 2012 in connection with the ITATS program.

The AN/ARM-206 ITATS program is proceeding well with the enhancements funded by the U.S. Navy last year now finished. The Company has completed final acceptance testing on the initial prototype units and has secured approval on these units in February 2012. The Company is currently undergoing its Production Readiness Review with the U.S. Navy.  The Company currently has orders for 102 units for approximately $5.3 million. It is expected that shipments will commence in the first half of calendar year 2013.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Dec. 31, 2012	Mar. 31, 2012
Common stock, par value (in Dollars per share)	$ 0.10	$ 0.10
Common stock, shares issued (in Shares)	3,000,639	2,684,215
Common stock, shares outstanding (in Shares)	3,000,639	2,684,215

XML

Note 12 - Litigation

9 Months Ended

Dec. 31, 2012

Legal Matters and Contingencies [Text Block]

Note 12 – Litigation

On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court, Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army (the “Award”), to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5. Aeroflex’s petition alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with its business relationship; conspired to harm Aeroflex and tortiously interfered with its contract and seeks injunctive relief and damages. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Award to the Company, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”). In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the Army Contracts Attorney and the Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed Aeroflex proprietary technology in winning the Award, and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.

In December 2009, the Kansas district court dismissed on jurisdiction grounds the Aeroflex Action. Aeroflex appealed this decision.  In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the district court for further proceedings. The district court has established discovery deadlines and the case is set for trial on January 14, 2014.  Tel is optimistic as to the outcome of this litigation.  However, the outcome of any litigation is unpredictable and an adverse decision in this matter could have a material adverse effect on our financial condition, results of operations or liquidity. 

XML

Document And Entity Information	9 Months Ended
	Dec. 31, 2012	Feb. 18, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	TEL INSTRUMENT ELECTRONICS CORP
Document Type	10-Q
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		3,011,739
Amendment Flag	false
Entity Central Index Key	0000096885
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2012
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3

XML

Note 13 - Restatement

9 Months Ended

Dec. 31, 2012

Restatement Of Prior Year Income [Text Block]

Note 13 – Restatement

The state and local deferred tax provision was increased for the year ended March 31, 2012 as a result of a change in New Jersey tax law which, in substance, lowered the New Jersey tax rate, which resulted in lowering the carrying value of the New Jersey net deferred tax assets and net income by $394,604 and $256,644, respectively. The New Jersey tax law change was effective for the first quarter of fiscal year 2012, ending June 30, 2011. As such, the accompanying statement of operations has been restated to reflect the adjustment to net income in the first quarter of fiscal year 2012. This change has also been reported in the Company’s report on Form 8-K filed on July 13, 2012. The Company did not lose any future benefit, and the result is such that the Company will have lower NJ tax expense in the future.

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Net sales	$ 2,350,020	$ 3,673,235	$ 5,922,258	$ 11,337,800
Cost of sales	1,896,652	2,227,856	4,582,773	6,547,563
Gross margin	453,368	1,445,379	1,339,485	4,790,237
Operating expenses:
Selling, general and administrative	587,146	724,636	1,927,380	2,191,332
Engineering, research and development	481,055	633,136	1,608,459	2,160,107
Total operating expenses	1,068,201	1,357,772	3,535,839	4,351,439
Income (loss) from operations	(614,833)	87,607	(2,196,354)	438,798
Other income (expense):
Amortization of debt discount	(37,948)	(13,386)	(82,349)	(40,177)
Amortization of debt expense	(68,384)	(27,081)	(152,175)	(81,241)
Financing Costs	(21,441)	0	(47,918)	0
Change in fair value of common stock warrants	19,710	130,433	268,767	66,738
Gain on sale of capital asset	0	500	0	500
Proceeds from life insurance policy	0	0	0	300,029
Interest income	420	224	433	418
Interest expense	(126,489)	(103,155)	(349,989)	(302,265)
Total other income (expense)	(234,132)	(12,465)	(363,231)	(55,998)
Income (loss) before income taxes	(848,965)	75,142	(2,559,585)	382,800
Income tax expense (benefit)	(303,788)	(22,289)	(915,903)	262,848
Net income (loss)	$ (545,177)	$ 97,431	$ (1,643,682)	$ 119,952
Basic income (loss) per common share (in Dollars per share)	$ (0.19)	$ 0.04	$ (0.59)	$ 0.05
Diluted income (loss) per common share (in Dollars per share)	$ (0.19)	$ 0.04	$ (0.59)	$ 0.04
Weighted average shares outstanding:
Basic (in Shares)	2,912,516	2,652,864	2,776,643	2,650,032
Diluted (in Shares)	2,912,516	2,706,078	2,776,643	2,718,720

XML

Note 7 - Stock Options

9 Months Ended

Dec. 31, 2012

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Note 7 – Stock Options

The Company adopted FASB ASC 718, utilizing the modified prospective method.  FASB ASC 718 requires the measurement of stock-based compensation based on the fair value of the award on the date of grant.  Under the modified prospective method, the provisions of ASC 718 apply to all awards granted after the date of adoption.  The Company recognizes compensation cost on awards on a straight-line basis over the vesting period, typically four years.  As a result of adopting ASC 718, operations were charged $16,607 and $62,884 for three months and nine months ended December 31, 2012, respectively, as compared to $21,830 and $68,324 for the three and nine months ended December 31, 2011, respectively. The Company estimates the fair value of each option using the Black Scholes option-pricing model with the following weighted-average assumptions: expected dividend yield of 0.0%, risk-free interest rate of 0.86% to 1.08%, volatility at 36.07% to 36.63% of the Company’s stock, and an expected life of 5 years for options granted for the nine months ended December 31, 2011. The Company estimates forfeiture rate based on historical data.  Based on an analysis of historical information, the Company applied a forfeiture rate of 8%. The Company did not grant any options during the nine months ended December 31, 2012.

XML

Note 6 - Long-Term Debt

9 Months Ended

Dec. 31, 2012

Long-term Debt [Text Block]

Note 6 – Long-Term Debt

In September 2010, the Company entered into an agreement with BCA Mezzanine Fund LLP (“BCA”) to loan the Company $2,500,000 in the form of a Promissory Note (the “Note”).  The Company incurred expenses of $541,604 in connection with this loan, including legal fees, investment banking fees and other transaction fees.  These expenses are included as deferred debt expense in the accompanying balance sheet, and these expenses are being amortized over the term of the loan.

The features of the Note are as follows:

(1)   The Note has a term of five (5) years with an annual interest rate of 14% on the outstanding principal amount.  Payments for the first year were interest only and amounted to $28,762 monthly.  In September 2011, the Company began making monthly payments of approximately $69,000 for interest and principal for the remaining term of the loan. BCA had agreed to allow the Company to defer principal payments for the three months ended September 30, 2012. BCA has also agreed to allow the Company to defer principal payments due on October 31 and November 30, 2012. These amounts are deferred until September 2015. BCA has also agreed to allow the Company to defer principal payments due on December 31, 2012 and January 31, 2013 to February 2013.

(2)   At inception, the Company issued BCA  a nine-year warrant for 136,090 shares, based upon 4.5% of the fully-diluted outstanding shares of the Company’s common stock exercisable at $6.70 per share, the average closing price of the common stock over the three days preceding the loan closing on the NYSE-MKT Exchange.  In the event of specific major corporate events or the maturity of the five-year loan, BCA can require the Company to purchase the warrant and warrant shares at the higher of the then Exchange market price less the share exercise price, in the case of the purchase of the warrant, or five times operating income per share. In connection with the warrant issued in conjunction with the issuance of this debt, the Company recorded a debt discount and warrant liability, which is being marked to fair value at the end of each period (see Note 10 to Notes to the Condensed Consolidated Financial Statements).  The debt discount is being amortized over the life of the loan.

(3)   Loan provisions also contain customary representations and warranties.

(4)   BCA has a lien on all of the Company’s assets.  In February 2011, BCA agreed to release part of its lien on Company assets to the U.S. Government to allow for progress billings up to $1,000,000.

(5)   The Company was required to pay prepayment fees if the Company decided to prepay a portion of the principal amount during the first two years of the loan. The Company may now prepay a portion of the principal amount without any prepayment penalty.  Each payment must be not less than $25,000 or multiples of $25,000 in excess thereof.

(6)   Upon the occurrence of a Change of Control (as defined in the Agreement) or within five (5) Business Days of an O’Hara Life Insurance Realization Event (as defined in the Agreement), the Company shall, in each case at the election of BCA, prepay by wire transfer the entire outstanding principal amount of the Note in accordance with the redemption prices (the “Mandatory Redemption Prices”) set forth below (expressed as a percentage of the outstanding principal amount being prepaid and shall pay 103% in the first year of the loan, 102% in the second year of the loan, and 100% thereafter), together with (x) Interest, if any, accrued and unpaid on the outstanding principal amount of the Note so prepaid through the date of such prepayment, (y) all reasonable out-of-pocket costs and expenses (including reasonable fees, charges and disbursements of counsel), if any, associated with such prepayment, and (z) all other costs, expenses and indemnities then payable under this Agreement (such amounts, collectively the “Mandatory Redemption Payment”).  If a Change of Control or O’Hara Life Insurance Realization Event shall occur during any Loan Year set forth below, the Mandatory Redemption Price shall be determined based upon the percentage indicated above for such Loan Year multiplied by the principal amount which is being prepaid.  At the  election of BCA, all or any portion of the Mandatory Redemption Payment may be paid in the form of common stock of the Company in marketable condition in lieu of cash and to the extent available and to the extent not restricted by any SBIC Regulations.  In the event BCA makes the election contemplated by the immediately preceding sentence, the Company shall issue to BCA that number of shares having an aggregate Current Market Price as of such issuance date equal to that portion of the Mandatory Redemption Payment subject to such election.

(7)   The Note contains a number of affirmative and negative covenants which restrict our operations.  The BCA agreement contains a number of affirmative and negative covenants. For the quarter ended December 31, 2012, the Company was not in compliance with four covenants related to maintaining agreed upon financial ratios for fixed charges, leverage and debt service as well as a requirement for earnings before interest, taxes, depreciation and amortization (EBITDA) However, the Company received a waiver from BCA on each of the above mentioned covenants.   

(8)   The Company and BCA have amended certain provisions to certain restrictions.

In consideration for the waiver for non-compliance of the financial covenants at March 31, 2012, BCA received warrants to purchase 20,000 shares of the Company’s common stock. The common stock underlying the warrant are exercisable at a price of $3.35 per share and the warrants expire on September 10, 2019. Determining the warrant value to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrant is calculated using the Black-Scholes valuation model. The value of the warrant was charged to financing costs in the accompanying statement of operations in the amount of $26,477 for the nine months ended December 31, 2012 (see Note 10).

In consideration for the waiver for non-compliance of the financial covenants as September 30, 2012 and for the deferral of principal payments due on October 31 and November 30, 2012 to the end of the term of the loan (maturity), BCA received warrants to purchase 20,000 shares of the Company’s common stock. The common stock underlying the warrants are exercisable at a price of $3.56 per share and the warrant expire on September 10, 2019. Determining the warrant value to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrant is calculated using the Black-Scholes valuation model. The value of the warrant was charged to financing costs in the accompanying statement of operations in the amount of $21,441 for the three and nine months ended December 31, 2012 (see Note 10).

In consideration for the waiver for non-compliance of the financial covenants as December 31, 2012 and for the deferral of principal payments due on December 31, 2012 and January 31, 2013, BCA received warrants to purchase 20,000 shares of the Company’s common stock. The common stock underlying the warrant is exercisable at a price of $3.58 per share and the warrants expire on September 10, 2019. Fair value of the warrant is calculated using the Black-Scholes valuation model. The value of the warrant is $23,714. In addition, the Company agreed to pay an additional closing fee of 1% of the original principal in the amount of $25,000.

On July 26, 2012 the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a private investor (the “Private Investor”).  Pursuant to the terms of the Purchase Agreement, the Company issued (i) a senior secured promissory note in favor of the Private Investor in the aggregate principal amount of $600,000, approximately $489,000 net of expenses, accruing interest at a rate of 14% per annum and (ii) a common stock purchase warrant to purchase 50,000 shares of the Company’s common stock, par value $0.10 per share. The Note, together with all unpaid interest and principal is due on March 31, 2013.  The common stock underlying the warrant is exercisable at a price of $3.35 per share and the warrant expires on September 10, 2019. In conjunction with the Purchase Agreement the Company entered into an (i) Investor Rights Agreement, (ii) Securities Agreement, (iii) Intercreditor Agreement and (iv) Subordination Agreement. The Company reported the foregoing on its Current Report on Form 8-K on August 3, 2012.

In connection with the warrant issued in conjunction with this debt, the Company recorded a debt discount and warrant liability, which is being marked to fair value at the end of each period (see Note 10 to Notes to the Condensed Consolidated Financial Statements).  The Company adopted the guidance of ASC 815, which requires that we mark the value of our warrant liability (see Note 10) to market and recognize the change in valuation in our statement of operations each reporting period. Determining the warrant liability to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrant calculated using the Black-Scholes valuation model was $65,193. The corresponding debt discount is being amortized over the life of the loan.

The new promissory note, dated July 26, 2012 with the Private Investor, contains a number of affirmative and negative covenants which restrict our operations.  The agreement contains a number of affirmative and negative covenants. For the quarter ended December 31, 2012, the Company was not in compliance with four covenants related to maintaining agreed upon financial ratios for fixed charges, leverage and debt service as well as a requirement for earnings before interest, taxes, depreciation and amortization (EBITDA).  However, the Company received a waiver on each of the above mentioned covenants.

XML

Note 5 - Loss Per Share (Tables)

9 Months Ended

Dec. 31, 2012

Schedule of Earnings Per Share Reconciliation [Table Text Block]

The Company’s basic income (loss) per common share is based on net income (loss) for the relevant period, divided by the weighted average number of common shares outstanding during the period. Diluted income per common share is based on net income, divided by the weighted average number of common shares outstanding during the period, including common share equivalents, such as outstanding stock options. Diluted loss per share for the three and nine months ended December 31, 2012 does not include common stock equivalents, as these stock equivalents would be anti-dilutive.

	Three Months Ended			Three Months Ended
	December 31, 2012			December 31, 2011
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(545,177	)	$	97,431
Weighted-average common shares outstanding		2,912,516			2,652,864
Basic net income (loss) per share attributable to        common stockholders	$	(0.19	)	$	0.04
Diluted net income (loss)  per share computation
Net income (loss) attributable to common stockholders	$	(545,177	)	$	$   97,431
Weighted-average common shares outstanding		2,912,516			2,652,864
Incremental shares attributable to the assumed exercise        of outstanding stock options		-			53,214
Total adjusted weighted-average shares		2,912,516			2,706,078
Diluted net income (loss) per share attributable to        common stockholders	$	(0.19	)	$	0.04

	Nine Months Ended			Nine Months Ended
	December 31, 2012			December 31, 2011
				(Restated)
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(1,643,682	)	$	119,952
Weighted-average common shares outstanding		2,776,643			2,650,032
Basic net income (loss) per share attributable to       common stockholders	$	(0.59	)	$	0.05
Diluted net income (loss) per share computation
Net income (loss) attributable to common stockholders	$	(1,643,682	)	$	119,952
Weighted-average common shares outstanding		2,776,643			2,650,032
Incremental shares attributable to the assumed exercise      of outstanding stock options		-			68,688
Total adjusted weighted-average shares		2,776,643			2,718,720
Diluted net income (loss) per share attributable to       common stockholders	$	(0.59	)	$	0.04

XML

Note 14 - Subscription Agreements

9 Months Ended

Dec. 31, 2012

Stockholders' Equity Note Disclosure [Text Block]

Note 14 – Subscription Agreements

On September 26, 2012, the Company secured an equity purchase commitment for up to $500,000 in total from the Chief Executive Officer, a director and an affiliate to the Company to be called upon at the Company’s discretion. The stock subscription agreements provide for the sale of up to $500,000 of newly issued restricted shares at a price of $3.60 per share, the closing average price of the Company’s common stock following the signing of the individual stock subscription agreements. All of the $500,000 has been called upon by the Company as of December 31, 2012, and the Company issued 138,890 shares of restricted stock in exchange for this amount to the three investors.   This financing will be used for general business purposes.

The price was determined to be fair by a Special Valuation Committee of the Board, composed of Messrs. Robert H. Walker and Robert A. Rice, who did not participate in this share purchase.

In November 2012, the Company received $500,000 from an investment group in exchange for 149,254 shares of newly issued Company common stock at a price of $3.35 per share. These funds will be used for general operating purposes.

XML

Note 10 - Fair Value Measurements

9 Months Ended

Dec. 31, 2012

Fair Value Disclosures [Text Block]

Note 10 – Fair Value Measurements

FASB ASC 820-10, Fair Value Measurements and Disclosures defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and expands disclosures about fair value measurements.

As defined in ASC 820-10, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price).  The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique.  These inputs can be readily observable, market corroborated, or generally unobservable.  The Company classifies fair value balances based on the observability of those inputs. ASC 820-10 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy defined by ASC 820-10 are as follows:

·   Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.  Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

·   Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.  Level 2 includes those financial instruments that are valued using models or other valuation methodologies.  These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.  Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.  Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

·   Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources.  These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

The valuation techniques that may be used to measure fair value are as follows:

·   Market approach — Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

·   Income approach — Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method.

·   Cost approach — Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).

The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility reflect currently available terms and conditions for similar debt.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of December 31 2012 and March 31, 2012.  As required by FASB ASC 820-10, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.

December 31, 2012	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		200,634		200,634
Total Liabilities	$	-	$	-	$	200,634	$	200,634

March 31, 2012	Level I		Level II		Level III		Total
Total Assets	$	-	$	-	$	-	$	-
Warrant liability		-		-		355,290		355,290
Total Liabilities	$	-	$	-	$	355,290	$	355,290

The Company adopted the guidance of ASC 815, which requires that we mark the value of our warrant liability (see Note 6) to market and recognize the change in valuation in our statement of operations each reporting period. Determining the warrant liability to be recorded requires us to develop estimates to be used in calculating the fair value of the warrant.  The fair value of the warrants is calculated using the Black-Scholes valuation model.

The following table provides a summary of the changes in fair value of our Level 3 financial liabilities from March 31, 2012 through December 31, 2012 as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to the liability held at December 31, 2012:

Level 3 Reconciliation	Beginning at beginning of period		Gains and losses for the period (realized and unrealized)			Purchases, issuances, sales and settlements, net		Transfers in or out of Level 3		Balance at the end of period
Warrant liability		355,290		(268,767	)		114,111				200,634
Total Liabilities	$	355,290	$	(268,767	)	$	114,111	$	-	$	200,634

(1)  $66,193 recorded as deferred debt expense and $47,918 recorded as financing costs

The common stock warrants were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign corporation.  The warrants do not qualify for hedge accounting, and, as such, all changes in the fair value of these warrants are recognized as other income/expense in the statement of operations until such time as the warrants are exercised or expire.  Since these common stock warrants do not trade in an active securities market, the Company recognizes a warrant liability and estimates the fair value of these warrants using the Black-Scholes options model using the following assumptions:

Values at Inception

Date of Warrant	Expiration  Date		Number of Warrants		Exercise  Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free  Interest Rate			Warrant  Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	6.70		28.51	%		9		2.81	%	$	267,848
09-10-2010		09-10-2015		10,416	$	6.70	$	6.70		28.51	%		5		1.59	%	$	13,808
07-26-2012		09-10-2019		50,000	$	3.35	$	3.90		42.04	%		7		0.94	%	$	66,193
07-26-2012		09-10-2019		20,000	$	3.35	$	3.90		42.04	%		7		0.94	%	$	26,477
11-20-2012		09-10-2019		20,000	$	3.56	$	3.50		42.45	%		6.83		1.09	%		21,441

Values at March 31, 2012

Date of  Warrant	Expiration  Date		Number of Warrants		Exercise Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free Interest Rate			Warrant Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	6.33		53.19	%		7.45		2.23	%	$	338,116
09-10-2010		09-10-2015		10,416	$	6.70	$	6.33		53.19	%		3.45		2.23	%	$	17,174

Values at December 31, 2012

Date of  Warrant	Expiration Date		Number of Warrants		Exercise  Price		Fair Market Value Per Share		Expected Volatility			Remaining Life in Years		Risk Free Interest Rate			Warrant Liability
09-10-2010		09-10-2019		136,920	$	6.70	$	3.65		42.07	%		6.70		1.18	%	$	93,222
09-10-2010		09-10-2015		10,416	$	6.70	$	3.65		42.07	%		2.70		0.36	%	$	2,572
07-26-2012		09-10-2019		50,000	$	3.35	$	3.65		42.07	%		6.58		1.18	%	$	58,612
07-26-2012		09-10-2019		20,000	$	3.35	$	3.65		42.07	%		6.58		1.18	%	$	23,444
11-20-2012		09-10-2019		20,000	$	3.56	$	3.65		42.07	%		6.75		1.18	%	$	22,784

The volatility calculation was based on the 36 months for the Company’s stock price prior to the measurement date, utilizing January 1, 2010 as the initial period, as the Company believes that this is the best indicator of future performance, and the source of the risk free interest rate is the US Treasury rate related to 10 year notes.  The exercise price is per the agreement, the fair market value is the closing price of our stock on the date of measurement, and the expected life is based on management’s current estimate of when the warrants will be exercised.  All inputs to the Black-Scholes options model are evaluated each reporting period.

XML

Note 8 - Segment Information

9 Months Ended

Dec. 31, 2012

Segment Reporting Disclosure [Text Block]

Note 8 – Segment Information

In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial.  There are no inter-segment revenues.

The Company is organized primarily on the basis of its avionics products.  The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors.  The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops.  The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments.

Management evaluates the performance of its segments and allocates resources to them based on gross margin.  The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific.  As a result, all operating expenses are not managed on a segment basis.  Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level.

The table below presents information about reportable segments within the avionics business for the three and nine month periods ending December 31, 2012 and 2011:

Three Months Ended  December 31, 2012	Avionics  Government		Avionics  Commercial		Avionics  Total			Corporate  Items			Total
Net sales		1,828,941		521,079		2,350,020			-			2,350,020
Cost of Sales		1,480,584		416,068		1,896,652			-			1,896,652
Gross Margin		348,357		105,011		453,368			-			453,368
Engineering, research, and development						481,055						481,055
Selling, general and administrative						264,627			322,519			587,146
Amortization of debt discount									37,948			37,948
Amortization of debt expense									68,384			68,384
Financing costs									21,441			21,441
Change in fair value of common stock warrants									(19,710	)		(19,710	)
Interest expense, net									126,069			126,069
Total expenses						745,682			556,651			1,302,333
Loss before income taxes						(292,314	)		(556,651	)		(848,965	)

Three Months Ended December 31, 2011	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales		3,163,220		510,015		3,673,235		-			3,673,235
Cost of Sales		1,841,826		386,030		2,227,856		-			2,227,856
Gross Margin		1,321,394		123,985		1,445,379		-			1,445,379
Engineering, research, and development						633,136					633,136
Selling, general and administrative						358,388		366,248			724,636
Amortization of debt discount						-		13,386			13,386
Amortization of debt expense						-		27,081			27,081
Financing costs						-		-			-
Change in fair value of common stock warrants						-		(130,433	)		(130,433	)
Interest expense, net						-		102,431			102,431
Total expenses						991,524		378,713			1,370,237
Income (loss) before income taxes					$	453,855	$	(378,713	)	$	75,142

Nine Months Ended  December 31, 2012	Avionics  Government		Avionics  Commercial		Avionics  Total			Corporate  Items			Total
Net sales		4,226,451		1,695,807		5,922,258			-			5,922,258
Cost of Sales		3,051,873		1,530,900		4,582,773			-			4,582,773
Gross Margin		1,174,578		164,907		1,339,485			-			1,339,485
Engineering, research, and development						1,608,459			-			1,608,459
Selling, general and administrative						891,764			1,035,616			1,927,380
Amortization of debt discount									82,349			82,349
Amortization of debt expense									152,175			152,175
Financing costs									47,918			47,918
Change in fair value of common stock warrants									(268,767	)		(268,767	)
Proceeds from life insurance									-			-
Interest expense, net									349,556			349,556
Total expenses						2,500,223			1,398,847			3,899,070
Loss before income						(1,160,738	)		(1,398,847	)		(2,559,585	)

Nine Months Ended  December 31, 2011	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales		9,470,103		1,867,697		11,337,800		-			11,337,800
Cost of Sales		5,342,873		1,204,690		6,547,563		-			6,547,563
Gross Margin		4,127,230		663,007		4,790,237		-			4,790,237
Engineering, research, and development						2,160,107		-			2,160,107
Selling, general and administrative						1,046,231		1,145,101			2,191,332
Amortization of debt discount						-		40,177			40,177
Amortization of debt expense						-		81,241			81,241
Financing costs						-		-			-
Change in fair value of common stock warrants						-		(66,738	)		(66,738	)
Proceeds from life insurance						-		(300,029	)		(300,029	)
Interest (income) expense, net						-		301,347			301,347
Total expenses						3,206,338		1,201,099			4,407,437
Income (loss) before income taxes					$	1,583,899	$	(1,201,099	)	$	382,800

XML

Note 9 - Income Taxes

9 Months Ended

Dec. 31, 2012

Income Tax Disclosure [Text Block]

Note 9 – Income Taxes

The Company adopted FASB ASC 740-10, Accounting for Uncertainty in Income Taxes, effective April 1, 2007.  ASC 740-10 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions.  The Company does not have any unrecognized tax benefits.

The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset in the accompanying December 31, 2012 and March 31, 2012 condensed consolidated balance sheets.  Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse (See Critical Accounting Policies – Income Taxes).

XML

Note 11 - Reclassifications

9 Months Ended

Dec. 31, 2012

Reclassifications [Text Block]

Note 11 – Reclassifications

Certain prior year and period amounts have been reclassified to conform to the current period presentation.

XML

Note 10 - Fair Value Measurements (Detail) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Financial Services Costs (in Dollars)	$ 21,441	$ 0	$ 47,918	$ 0
Fair value assumptions, volatility, description			36 months
Fair Value Assumptions, Risk Free Interest Rate, Description			10 year notes
Deferred Debt Expense [Member]
Debt Issuance Cost (in Dollars)			$ 66,193

XML

Note 3 - Accounts Receivable, net (Tables)

9 Months Ended

Dec. 31, 2012

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

The following table sets forth the components of accounts receivable:

	December 31, 2012			March 31, 2012
Government	$	338,924		$	1,272,436
Commercial		349,462			457,670
Less: Allowance for doubtful accounts		(35,470	)		(35,470	)
	$	652,916		$	1,694,636

XML

Note 2 - Revenue Recognition - Percentage-of-Completion - ITATS ("Intermediate Level TACAN Test Set") (AN/ARM-206) (Detail) (USD $)	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Increase (Decrease) in Billing in Excess of Cost of Earnings	$ 0	$ (424,202)
Number of units for production delivery order	102
Value of Production Delivery Order	5,300,000
ITATS Program [Member]
Increase (Decrease) in Billing in Excess of Cost of Earnings	$ 0

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income (loss)	$ (1,643,682)	$ 119,952
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred income taxes	(919,814)	261,572
Depreciation and amortization	160,140	117,376
Allowance for bad debts	0	(1,200)
Provision for inventory obsolescence	0	1,971
Gain on sale of asset	0	(500)
Amortization of debt discount	82,349	40,177
Amortization of debt expense	152,174	81,241
Increase in cash surrender value of life insurance	0	2,011
Proceeds from life insurance policy	0	(300,029)
Warrants issued in exchange for services	47,918	0
Change in fair value of common stock warrant	(268,767)	(66,738)
Non-cash stock-based compensation	62,884	68,324
Changes in assets and liabilities:
Decrease in accounts receivable	1,041,720	817,002
Decrease in unbilled government receivables	728,724	0
Increase in inventories	(1,780,056)	(817,564)
Decrease (increase) in prepaid expenses & other	126,381	(66,572)
Increase in other assets	0	(36,302)
Increase in accounts payable	1,150,140	876,047
Decrease in accrued payroll, vacation pay & withholdings	(70,661)	(34,873)
Decrease in deferred revenues	(13,125)	(17,436)
Increase (decrease) increase in progress billings	0	(424,202)
Decrease in accrued expenses	(527,446)	(90,025)
Net cash (used in) provided by operating activities	(1,671,121)	530,232
Cash flows from investing activities:
Proceeds from the sale of capital asset	0	500
Purchases of equipment	(60,816)	(149,161)
Net cash used in investing activities	(60,816)	(148,661)
Cash flows from financing activities:
Proceeds from the exercise of stock options	104,430	21,749
Proceeds from the sale of common stock	1,000,002	0
Proceeds from long-term debt	600,000	0
Expenses associated with long-term debt	(111,340)	0
Repayment of long-term debt	(127,929)	(158,493)
Repayment of capitalized lease obligations	(47,627)	(41,295)
Proceeds from life insurance policy	0	312,683
Net cash provided by financing activities	1,417,536	134,644
Net (decrease) increase in cash and cash equivalents	(314,401)	516,215
Cash and cash equivalents at beginning of period	413,195	123,955
Cash and cash equivalents at end of period	98,794	640,170
Taxes paid	0	0
Interest paid	261,413	269,131
Capitalized lease obligations	$ 0	$ 254,734

XML

Note 5 - Loss Per Share

9 Months Ended

Dec. 31, 2012

Earnings Per Share [Text Block]

Note 5 – Loss Per Share

Financial Accounting Standards Board (“FASB”) ASC 260 requires presentation of basic earnings per share (“basic EPS”) and diluted earnings per share (“diluted EPS”).

The Company’s basic income (loss) per common share is based on net income (loss) for the relevant period, divided by the weighted average number of common shares outstanding during the period.  Diluted income per common share is based on net income, divided by the weighted average number of common shares outstanding during the period, including common share equivalents, such as outstanding stock options.  Diluted loss per share for the three and nine months ended December 31, 2012 does not include common stock equivalents, as these stock equivalents would be anti-dilutive.

	Three Months Ended			Three Months Ended
	December 31, 2012			December 31, 2011
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(545,177	)	$	97,431
Weighted-average common shares outstanding		2,912,516			2,652,864
Basic net income (loss) per share attributable to        common stockholders	$	(0.19	)	$	0.04
Diluted net income (loss)  per share computation
Net income (loss) attributable to common stockholders	$	(545,177	)	$	$   97,431
Weighted-average common shares outstanding		2,912,516			2,652,864
Incremental shares attributable to the assumed exercise        of outstanding stock options		-			53,214
Total adjusted weighted-average shares		2,912,516			2,706,078
Diluted net income (loss) per share attributable to        common stockholders	$	(0.19	)	$	0.04

	Nine Months Ended			Nine Months Ended
	December 31, 2012			December 31, 2011
				(Restated)
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(1,643,682	)	$	119,952
Weighted-average common shares outstanding		2,776,643			2,650,032
Basic net income (loss) per share attributable to       common stockholders	$	(0.59	)	$	0.05
Diluted net income (loss) per share computation
Net income (loss) attributable to common stockholders	$	(1,643,682	)	$	119,952
Weighted-average common shares outstanding		2,776,643			2,650,032
Incremental shares attributable to the assumed exercise      of outstanding stock options		-			68,688
Total adjusted weighted-average shares		2,776,643			2,718,720
Diluted net income (loss) per share attributable to       common stockholders	$	(0.59	)	$	0.04

XML

Note 3 - Accounts Receivable, net (Detail) - Schedule of Accounts Receivable (USD $)	Dec. 31, 2012	Mar. 31, 2012
Less: Allowance for doubtful accounts	$ (35,470)	$ (35,470)
	652,916	1,694,636
Government Receivables [Member]
Accounts Receivable	338,924	1,272,436
Commercial Receivables [Member]
Accounts Receivable	$ 349,462	$ 457,670

XML

Note 13 - Restatement (Detail) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Tax Credit Carryforward, Deferred Tax Asset	$ 394,604		$ 394,604
Net Income (Loss) Attributable to Parent	(545,177)	97,431	(1,643,682)	119,952
Restate Prior Year Income [Member]
Net Income (Loss) Attributable to Parent			$ 256,644

XML

Note 15 - New Accounting Pronouncements

9 Months Ended

Dec. 31, 2012

New Accounting Pronouncements, Policy [Policy Text Block]

Note 15 – New Accounting Pronouncements

For the nine months ended December 31, 2012, there have been no significant accounting pronouncements or changes in accounting pronouncements that have become effective that are expected to have a material impact on the Company’s financial position, operations or cash flows.